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CHAPTER I 
 
BACKGROUND AND LITERATURE REVIEW 
 
Introduction 
 Coronaviruses are a family of enveloped, positive-strand RNA viruses, which are 
important pathogens of both humans and animals.  Coronaviruses are widely dispersed 
among mammals and birds and can cause a multitude of enteric, gastrointestinal, 
neurological, and respiratory illnesses.  In humans, however, disease is usually limited to 
the upper respiratory tract, and approximately 5 to 20% of yearly common colds are 
caused by coronaviruses (Engel, 1995; Makela et al., 1998).  Because coronaviruses were 
previously not associated with severe human disease, these viruses were scientifically and 
agriculturally important, but not considered medically important pathogens of humans.  
However, enthusiasm in the coronavirus field intensified in the past few years due to the 
identification of a newly emerged coronavirus as the causative agent of severe acute 
respiratory syndrome (SARS). 
 In late 2002, multiple cases of severe atypical pneumonia were reported in 
southern China.  As additional cases of severe, often fatal respiratory disease began to 
spread throughout the world in early 2003, worldwide health organizations began a 
collaborative effort to identify the unknown pathogen.  The cooperation of the 
international organizations led to the identification of a newly emerged coronavirus as the 
causative agent of SARS within a matter of weeks after its emergence.  The newly 
discovered coronavirus was named after the disease it caused, severe acute respiratory 
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syndrome coronavirus, or SARS-CoV.  Between November 2002 and July 2003, over 
8400 individuals in 32 countries were diagnosed with SARS.  Over 900 infected 
individuals succumbed to the disease before the pandemic was controlled in late 2003 
(Ksiazek et al., 2003; Kuiken et al., 2003a; Kuiken et al., 2003b; Marra et al., 2003). 
 The identification of a novel coronavirus as the etiological agent of SARS in 2003 
resulted in a new awareness of the potential for severe disease in humans, as well as 
demonstrating their potential for transspecies movement and pathogenicity.  Following 
the SARS epidemic, increased surveillance led to the discovery of previously unidentified 
coronaviruses in numerous animals, as well as in archival tissue samples. The SARS 
epidemic also resulted in increased focus on research aimed at elucidating the 
mechanisms by which coronaviruses move between species, replicate, and cause disease.  
The research presented in this dissertation uses the coronavirus murine hepatitis virus 
(MHV) as a model to gain a more complete understanding of specific events that take 
place in the coronavirus life cycle. 
 Proteins encoded within the replicase gene are proposed to mediate coronavirus 
replication in host cells.  The replicase gene is translated as a polyprotein that is co- and 
post-translationally processed into intermediate and mature replicase nonstructural 
proteins (nsps) by virus-encoded proteases (Anand et al., 2003; Baker et al., 1993; Bost et 
al., 2000; Denison et al., 1998; Denison et al., 1992; Dong and Baker, 1994; 
Kanjanahaluethai and Baker, 2000; Kim et al., 1995; Lu, Sims, and Denison, 1998a; Lu, 
Lu, and Denison, 1995; Schiller, Kanjanahaluethai, and Baker, 1998; Thiel et al., 2003; 
Weiss et al., 1994).  These proteins localize to virus-induced double membrane vesicles 
in the cytoplasm of infected cells, which also are sites of viral RNA synthesis (Gosert et 
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al., 2002; Prentice et al., 2004).  While functions of some replicase intermediate and 
mature proteins have been identified in infected cells, the functions of others remained to 
be determined.  However, the establisment of reverse genetics systems for multiple 
coronaviruses likely will lead to the discovery of several new functions of these proteins. 
 When this research began, it was known that protease inhibitors that block overall 
polyprotein processing abort new viral RNA synthesis when added at any time during 
MHV infection, demonstrating the overall requirement for ongoing processing of 
replicase polyproteins in virus replication (Kim et al., 1995). It was also known that the 
coronavirus-encoded proteases processed the replicase polyprotein at specific amino acid 
sequences, and that the patterns of processing at cleavage sites by specific proteases 
differed among many coronaviruses (Ziebuhr, Snijder, and Gorbalenya, 2000).  
Moreover, protease and cleavage site interactions are key genetic determinants of protein 
functions and important in the regulation of the life cycles of coronaviruses.  However, 
little was known about the evolution of protease/cleavage site relationships and 
determinants of conserved and unique protease functions in the coronavirus life cycle.  
Further, with the exception of the viral proteases and the C-terminal replicase proteins, 
little was also known about the functions of nsp1, nsp2, nsp3, and nsp4 (Baker et al., 
1989; Baker et al., 1993; Kanjanahaluethai and Baker, 2000; Lee et al., 1991; Lu, Lu, and 
Denison, 1995).  Thus, at the time this research began, several gaps in knowledge existed 
about the functions and requirements of protease/cleavage site recognition and processing 
and the roles that the N-terminal replicase proteins play during coronavirus replication. 
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Coronavirus identification and classification 
 The members of the family Coronaviridae are spherical, enveloped viruses whose 
surfaces are studded with many trimers of the viral Spike glycoprotein, which can be 
visualized as a halo or crown surrounding the particle when viewed by negative-stain 
electron microscopy (Fig 1.1), hence giving the family its “corona” name. Since the 
identification of avian infectious bronchitis virus (IBV) in chickens in 1937, more than 40 
other coronaviruses have been isolated from various birds and mammals, including 
turkeys, ducks, pigs, dogs, cats, cows, mice, giraffes, bats, deer, whales, and humans. 
 The coronavirus virion contains a large, single-stranded, positive-sense RNA 
genome.  Through negative-stain electron microscopy and biochemical analysis, the 
nucleocapsid symmetry of coronaviruses was determined to be helical in nature (Masters, 
2006).  This was quite surprising given the fact that helical symmetry is commonly 
observed for negative-sense RNA viruses, while almost all positive-sense RNA animal 
viruses possess icosahedral nucleocapsids.  However, evidence has also supported 
icosahedral symmetry for the coronavirus transmissible gastroenteritis virus (TGEV) 
(Risco et al., 1996). 
 Coronaviruses belong to the order Nidovirales and are currently classified as one 
of two genera, the other being the toroviruses, in the Coronaviridae family.  It is likely, 
however, that both the coronaviruses and toroviruses will be separated and classified as 
distinct families in the future (Gonzalez et al., 2003). The order Nidovirales also includes  
two other families, the Arteriviridae and the Roniviridae.  Together, the nidoviruses 
exhibit a high level of organization that sets them apart from other nonsegmented 
positive-sense RNA viruses.  Features of the Nidovirales include:  expression of the  
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Fig. 1.1.  Coronavirus virion structure.  Left) Schematic of coronavirus virion.  The structural 
proteins of the virion are indicated by arrows and abbreviations (S, E, M, and N).  The spike attachment 
protein (S) mediates attachment to the receptor on the surface of a permissive cell.  M protein (M) is 
threaded through the lipid bilayer envelope, which is derived from the host cell.  M protein mediates 
curvature of the virion envelope during budding.  Nucleocapsid (N) coats the viral RNA and maintains 
the helical conformation of genome RNA.  The envelope protein (E) is present in low copy number in 
virion membrane, and together with M, is involved in membrane curvature and pinching off of the 
budding virion.  Right) A negative-stain electron micrograph of an MHV virion.  The horizontal black 
bar represents 100 nm.  Images from J. Sparks. 
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entire replicase polyprotein via ribosomal frameshifting; unique enzymatic activities not 
seen in other positive-strand RNA viruses; and gene expression through the transcription 
and translation of a set of 3’-coterminal “nested” subgenomic RNAs.  This latter feature 
is the basis for the name of the order, with “nido” being the Latin word for nest. 
 At the initiation of this research, the coronaviruses were classified into four 
groups, group 1, 2a, 2b, and 3, originally based on antigenic relationships through 
utilization of neutralizing antibody assays.  However, the discovery of new 
coronaviruses, extensive genome sequencing, and bioinformatics databases has aided in 
the current classification of coronaviruses (Gorbalenya, Snijder, and Spaan, 2004).  Also, 
these scientific advances have led to the proposal for a reclassification of coronaviruses.  
However, a new classification system has yet to be widely accepted and received from 
the coronavirus field.   
 For both group 1 and group 2 coronaviruses, the hosts are almost exclusively 
mammalian, with human coronaviruses present in each of these groups.  Group 1 
coronaviruses include human coronaviruses, such as HCoV-229E and HCoV-NL63, as 
well as feline coronaviruses (FCoV and FIPV) and porcine coronaviruses (TGEV and 
PRCoV).  The group 2 viruses have been subdivided into two groups, groups 2a and 2b.  
Group 2a coronaviruses include the human coronavirus OC43 (HCoV-OC43), HCoV-
HKU1, murine hepatitis virus (MHV), and bovine coronavirus (BCoV).  Group 2b 
coronaviruses consist of viruses with a predicted earlier evolutionary offshoot of group 
2a, and these viruses include SARS-CoV and newly identified coronaviruses of bats (bat-
SARS-CoV) that resemble SARS-CoV.  Group 3 coronaviruses are currently known to 
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only have avian hosts.  This group includes viruses that infect chickens (IBV), turkeys 
(TCoV), pigeons (PCoV), and waterfowl, specifically geese (GCoV) and ducks (DCoV). 
 
Coronavirus disease 
 Coronaviruses are pathogens of both humans and animals and have both medical 
and agricultural importance.  Diseases caused by coronaviruses include, but are not 
limited to, gastrointestinal, respiratory, and neurological diseases.  Coronavirus infections 
can be either acute or persistent, and infections can be systemic or restricted to specific 
organ systems.  Though the specific determinants of coronavirus pathogenesis remain 
undefined, it is thought that both viral replication and host immune responses contribute 
to the overall severity of disease (Compton, Barthold, and Smith, 1993; Perlman and 
Netland, 2009). 
 Coronavirus infections of humans usually result in mild upper respiratory illness 
with cold-like symptoms (HCoV-229E and HCoV-OC43) that is resolved with little to no 
treatment necessary (Engel, 1995; Makela et al., 1998).  However, patients who were 
infected with SARS-CoV exhibited lower respiratory tract infection with atypical 
pneumonia, alveolar damage, pulmonary lesions, and appearance of mononuclear 
infiltrates, with many individuals succumbing to what was described as acute respiratory 
distress syndrome (ARDS) (Lai, 2003).  The identification of a novel coronavirus 
associated with severe respiratory disease prompted investigators to explore the 
possibility that other respiratory tract infections may be caused by coronaviruses.  
Inspections of archived nasopharyngeal aspirates led to the identification of new human 
coronaviruses, including HCoV-HKU1, which is associated with pneumonia, and HCoV-
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NL63, which causes bronchiolitis (Arden et al., 2005; Ebihara et al., 2005; Woo et al., 
2005).   
 The prototypical model for studies of coronavirus replication and pathogenesis is 
MHV, which can cause acute and persistent infections in mice.  The type of infection and 
severity of disease is dependent upon the viral strain (e.g. MHV-A59, MHV-2, MHV-
JHM, or MHV-S), the age of the animal, and the route of inoculation (Chen and 
Subbarao, 2007; Compton, Barthold, and Smith, 1993).  The two most well documented 
strains are MHV-A59 and MHV-JHM, which cause severe hepatitis and fatal 
demyelinating encephalitis, respectively, in naturally infected mice.  The Denison 
laboratory uses MHV-A59 (hereafter referred to as MHV) as a model to investigate 
mechanisms of coronavirus replication. 
 
Emergence and identification of new coronaviruses 
 While the host range of the coronavirus family is broad, most coronaviruses 
naturally infect only one animal species, or at most, a limited number of closely related 
species.  An exception appears to be SARS-CoV, which is suspected to have been 
transmitted from animal reservoirs to humans.  Based on post-pandemic surveillance of 
coronaviruses from animal populations, it is likely that SARS-CoV transitioned into the 
human population from endemically infected animals that showed no symptoms of 
disease.  SARS-like coronaviruses have been isolated from animals in China, including 
Himalayan palm civets, raccoon dogs, and most recently, Chinese horseshoe bats (Lau et 
al., 2005; Normile, 2005; Vijayanand, Wilkins, and Woodhead, 2004; Wang et al., 2005).  
Interestingly, the virus that infects these animals is genetically distinct from the variants 
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isolated in humans.  This is somewhat expected due to altered species specificity, but 
sequence analysis revealed that there is considerable genetic variation between the 
viruses isolated over the course of the SARS pandemic, especially within the 5’ third of 
the replicase (Chinese, 2004).  These findings suggest that there is extraordinary 
flexibility within the coronavirus genome.  Since the emergence of SARS-CoV, new and 
uncharacterized coronaviruses have also been identified from new hosts (Decaro et al., 
2008; Hasoksuz et al., 2007; Mihindukulasuriya et al., 2008), demonstrating that 
coronaviruses also have the capacity to rapidly adapt to and evolve in new host species. 
 
Coronavirus life cycle 
 The life cycle of coronaviruses occurs in the cytoplasm of host cells (Fig. 1.2).  
Attachment of the virion to the host cell surface via a cellular receptor is the first step in 
the life cycle of coronaviruses.  Attachment occurs by interactions between the spike (S) 
glycoprotein and a cell surface receptor.  The cellular receptor for MHV is 
carcinoembryonic antigen cell adhesion molecule-1a (CEACAM-1a) (Dveksler et al., 
1991; Williams, Jiang, and Holmes, 1991), and the cellular receptor for SARS-CoV is 
human angiotensin converting enzyme-2 (hACE-2) (Li et al., 2003).  Following 
attachment, the viral genome then enters the cell by either direct fusion of the viral lipid 
envelope with the plasma membrane or by fusion of the viral lipid envelope with an 
endosomal compartment following receptor-mediated endocytosis (Gallagher and 
Buchmeier, 2001; Kooi, Cervin, and Anderson, 1991). 
  After entry into a host cell, the first open reading frame (ORF1) of the 
RNA genome is translated by cellular ribosomes.  ORF1 constitutes approximately two-
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thirds of the genome and encodes nonstructural proteins (nsps) 1-16, which are necessary 
for viral RNA synthesis (Fig. 1.3).  The replicase gene encodes ORF1, which is 
comprised of two open reading frames (ORF1a and ORF1ab) that are connected by a -1 
ribosomal frameshift (Bonilla, Gorbalenya, and Weiss, 1994; Breedenbeek et al., 1990; 
Brierley, 1989; Lee et al., 1991; Pachuk et al., 1989).  Translation of ORF1a or ORF1ab 
results in polyproteins, either pp1a  (~495-kDa) or pp1ab (~803-kDa) that are co- and 
post-translationally processed by either two or three virus-encoded proteases, including 
either one or two papain-like protease (PLP) domains within nsp3 and the 3C-like 
cysteine protease, otherwise referred to as 3CLpro or nsp5, to yield intermediate and 
mature forms of nsps 1-16.  All tested nsps to date associate with replication complexes, 
which are responsible for viral RNA synthesis (Bost et al., 2000; Gosert et al., 2002). 
 Viral RNA synthesis, discussed later in this chapter, involves both genome 
replication and subgenomic mRNA transcription.  Genome RNA is replicated via a 
minus-strand intermediate template.  Subgenomic mRNAs are generated from genome 
RNA to allow for translation of structural and other accessory proteins from the ORFs 
downstream of ORF1 (Sawicki, Sawicki, and Siddell, 2007). 
 Coronavirus virions contain four structural proteins, S (spike), E (envelope), M 
(membrane protein), and N (nucleocapsid).  S, E, M, and N are translated from 
subgenomic RNAs 3, 5, 6, and 7, respectively, for MHV.  Virion assembly is mediated 
by E and M proteins interacting with membranes of the ERGIC, resulting in partial 
curvature of the membrane (Raamsman et al., 2000). E and M proteins are essential for 
the production of infectious virions, and expression of E and M in the absence of virus
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Fig. 1.2.  Coronavirus life cycle.  Step 1: Coronaviruses attach to receptors on the surface of cells 
(CEACAM-1a for MHV), which mediates fusion and entry.  Step 2: Open reading frame 1 of the 
positive-sense genome RNA is translated into replicase polyproteins.  Step 3: The replicase 
polyproteins are autoproteolytically processed into intermediate and mature replicase proteins.  Step 
4: These proteins associate with virus-induced double membrane vesicles in the cell cytoplasm to 
form replication complexes.  Step 5: These replication complexes mediate the synthesis of viral RNA, 
including genomic and subgenomic (minus-strand (purple) and plus-strand (blue)) species.  Step 6: 
Genome RNA is delivered to sites of assembly in the ER-Golgi Intermediate Compartment (ERGIC), 
where it is packaged into virions.  Step 7: Virions are shuttled to the cell surface in vesicles that (Step 
8) fuse with the cell surface, releasing the virus progeny in a process that does not require cell lysis.  
Schematic provided by R. Graham. 
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infection has been shown to produce empty virus-like particles (Curtis, Yount, and Baric, 
2002; Kuo and Masters, 2002; Ortego et al., 2002; Vennema et al., 1996).  Direct 
molecular interactions between M-S, M-N, N-RNA, and M-RNA result in the packaging 
of these components into budding virions (Narayanan et al., 2000; Opstelten, Horzinek, 
and Rottier, 1993; Opstelten et al., 1995; Vennema et al., 1991).  The E protein then aids 
in pinching off of the virion from membranes of the ERGIC ((Fischer et al., 1998).  Then, 
coronavirus virions are shuttled to the plasma membrane in large exocytic vesicles, and 
virions are released from the cell in a process that does not require cell lysis.  The length 
of time to complete the life cycle varies depending on coronavirus.  For MHV, the life 
cycle lasts approximately 10 to 16 hours. 
 
Translation and processing of the coronavirus replicase 
 Upon entry into the host cell, the positive-strand RNA genome of coronaviruses 
functions as an mRNA, from which ORF1 is translated by host cell ribosomes.  ORF1 is 
translated as a polyprotein, either massing approximately 500-kDa (polyprotein 1a 
[pp1a]) or, due to a -1 ribosomal frameshift, 800-kDa (pp1ab) (Bonilla, Gorbalenya, and 
Weiss, 1994; Breedenbeek et al., 1990; Brierley, 1989; Lee et al., 1991; Pachuk et al., 
1989).  Pp1a and pp1ab are co- and post-translationally processed by virus-encoded 
proteases into intermediate and mature proteins (Fig 1.3).  The number of proteases 
varies depending on the particular coronavirus.  All coronaviruses encode 3CLpro within 
nsp5 (Lu, Lu, and Denison, 1996), which is responsible for mediating processing from 
the C-terminus of nsp4 through nsp16 (Bost et al., 2000; Denison et al., 1998; Denison et 
al., 1999; Lu, Sims, and Denison, 1998a).   
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 For processing of nsps 1 through the N-terminus of nsp4, coronaviruses encode 
either one or two papain-like proteases (PLPs) within nsp3 (Bonilla et al., 1995; Bonilla, 
Hughes, and Weiss, 1997; Dong and Baker, 1994; Kanjanahaluethai and Baker, 2001; 
Teng, Pinon, and Weiss, 1999; Ziebuhr, Snijder, and Gorbalenya, 2000).  Group 1 and 
group 2a coronaviruses, such as HCoV-229E and MHV, respectively, each encode two 
PLPs, PLP1 and PLP2, to process the first three cleavage sites (CSs), or nsp1 through the 
N-terminus of nsp4.  Group 2b and 3 coronaviruses encode only one enzymatically active 
PLP in the position of PLP2 that is similar to group 1 and 2a coronaviruses.  IBV also 
possesses an inactive PLP remnant in the position of PLP1, while SARS-CoV has little to 
no sequence homology to a PLP domain located in or near the PLP1 position within nsp3 
(Fig. 1.4) (Snijder et al., 2003).  The basis for part of this dissertation is the observation 
that different coronaviruses appear to have evolved related, but distinct, strategies for 
processing of the N-terminal CSs with PLPs.  The importance of the use of one or two 
PLPs in virus evolution, replication, and pathogenesis is currently unknown. 
 Prior to research presented in this dissertation, studies have utilized protease 
inhibitors to abolish polyprotein processing of the replicase, and results revealed that 
virus-mediated protein processing was essential for ongoing viral RNA synthesis and 
virus replication (Kim et al., 1995).  Studies have also identified the CS amino acid 
sequences and residues that are critical in the recognition and processing of the 
polyproteins by coronavirus proteases (see review by (Ziebuhr, Snijder, and Gorbalenya, 
2000).  These studies have led to the identification of preferred residues in certain 
positions of the CS amino acid sequences, and it appears that different residues in these  
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Fig. 1.3.  Murine hepatitis virus genome organization and ORF1 translation and 
processing.  Coronavirus genomes are between 27 kb and 32 kb in length.  The 31.5 kb genome 
of MHV contains 7 genes.  ORF1 encodes the replicase polyprotein, and downstream ORFs 
encode structural and accessory proteins.  ORF1 has two open reading frames, ORF1a, which 
encodes an ~495 kDa polyprotein and ORF1ab, which, when translated, encodes an ~800 kDa 
polyprotein.  The polyprotein is then co- and post-translationally processed into intermediate and 
mature proteins.  Mature proteins are distinguished by vertical lines and indicated by 
nonstructural protein (nsp) number.  The vertical lines also indicate cleavage sites.  Viral papain-
like proteases are indicated by green boxes and by number (PLP1 or PLP2).  The viral 3C-like 
protease (3CLpro) is indicated by a red box (nsp5).  Cleavage sites are assigned to a protease 
group by the linked colored background.  Proteases and other key proteins are indicated below 
the schematic.  RdRp, RNA-dependent RNA polymerase; Hel, helicase; ExoN, exoribonuclease; 
Endo, endoribonuclease; MT, methyltransferase. 
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positions may control the timing and/or regulation of the production of intermediate and 
mature proteins during protein processing. 
 
Coronavirus nsps 1 through 4 
 The 5’ third of the coronavirus ORF1, encoding nsps 1, 2, 3, and 4, has 
considerable variability across coronavirus groups, such as the presence or absence of 
nsp1, low amino acid sequence similarity and sizes of nsp1 and nsp2, the presence of one 
or two PLPs within nsp3, and differences in the number of predicted transmembrane 
domains within nsp4.  Most of the variations within nsps 1 through 4 are observed 
between divergent coronavirus groups, and it has been proposed that the proteins in this 
region have evolved to adapt to their specific hosts (de Vries et al., 1997).  Even though 
there is considerable diversity within this region of the polyprotein, several proteins or 
domains have been shown to have similar activities during viral infection. 
 Nsp1 varies in size between coronavirus groups 1, 2a, and 2b,  and group 3 
coronaviruses, such as IBV, do not encode nsp1.  Upon translation of ORF1 for MHV, 
nsp1 is co-translationally processed and only detected as a mature protein.  For MHV and 
SARS-CoV, nsp1 has been shown to inhibit host gene expression and is a major 
pathogenicity factor involved in the suppression of innate immune functions (Kamitani et 
al., 2006; Narayanan et al., 2008; Zust et al., 2007).   
 Like nsp1, coronavirus nsp2 varies in size between coronavirus groups, ranging 
from 65-kDa (MHV) to 87-kDa (HCoV-229E and IBV).  It has no known function and 
aligns poorly to proteins with defined function(s).  MHV nsp2 is detected as a mature 
protein, as well as an nsp2-3 intermediate, and localizes to replication complexes 
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throughout the course of infection (Bost, Prentice, and Denison, 2001).  Nsp2 is not 
required for virus replication of MHV and SARS-CoV and can be deleted from the 
replicase polyprotein (Graham et al., 2005).  
 Nsp3 shares several conserved domains among coronaviruses, including an Ac 
domain highly enriched in acidic residues and a C-terminal Y domain that possesses 
putative transmembrane domains (Kanjanahaluethai et al., 2007).  Nsp3 also shares an X 
domain that has sequence homology to the adenosine diphosphate ribose-1” phosphatase.  
This domain has been shown to be important in producing liver disease and pathology in 
MHV (Eriksson et al., 2008).  Nsp3 also possesses either one or two papain-like protease 
(PLP) domains, whose activities, substrate specificities, and requirements have been 
demonstrated in vitro (Bonilla et al., 1995; Bonilla, Hughes, and Weiss, 1997; Dong and 
Baker, 1994; Hughes, Bonilla, and Weiss, 1995; Kanjanahaluethai and Baker, 2000; 
Teng, Pinon, and Weiss, 1999).  These proteases also have a zinc ribbon domain located 
within each of the protease domains.  Because of these unique features of nsp3, it clearly 
plays a role in both translation and processing of the replicase polyprotein.  This protein 
may also play other roles in the virus life cycle, such as induction and stability of virus-
induced membrane rearrangements (Y domain) and transcription (Ac domain and X 
domain). 
 Like nsp2, little is known about the function of nsp4.  Nsp4 is unique among 
coronavirus nsps in that it is processed at its N-terminus by a PLP and at its C-terminus 
by 3CLpro (Gosert et al., 2002; Harcourt et al., 2004; Kanjanahaluethai and Baker, 2000; 
Kanjanahaluethai and Baker, 2001; Kanjanahaluethai, Jukneliene, and Baker, 2003).  For 
MHV, nsp4 is either detected in its mature form or as an nsp4-10 intermediate protein. 
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Fig 1.4.  Comparison of coronavirus nsp1-nsp4 proteins.  A) Nsp1 through nsp4 of 
representative coronaviruses (MHV: group 2a; SARS-CoV: group 2b; HCoV-229E: group 1; IBV: 
group 3) are shown, with proteins indicated by nsp number.  Papain-like proteases are indicated by 
gray boxes and number.  A hatched gray box represents an inactive remnant of the IBV PLP1 
domain.  Other domains within nsp3 are indicated by white boxes.  Cleavage events mediated by 
papain-like proteases are illustrated by arrows.  B) Known or predicted molecular weights of nsp1, 
2, 3, and 4 are shown, with mass in kDa.  Adapted from R. Graham. 
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Due to the hydrophobic nature of nsp4, it was predicted to play roles in the formation, 
organization, and stability of virus-induced membrane rearrangements that are essential 
for viral RNA synthesis and virus replication. 
 
Papain-like protease structure, specificity, and activities 
 The three-dimensional structure of the SARS-CoV PLP, PLpro, has been 
determined by X-ray crystallography (Ratia et al., 2006).  The solved structure verified 
many of the features that were proposed for the HCoV-229E PLP2 catalytic core, 
confirming the papain and hTFIIS-based homology models (Herold, Siddell, and 
Gorbalenya, 1999).  The structure of SARS-CoV PLpro revealed a fingers-palm-thumb 
architecture and a catalytic triad consisting of Cys-His-Asp residues (Fig. 1.5).  The 
structure consists of a zinc ribbon domain (fingers), a papain-like fold composed of β-
sheets (palm), and an α-helix domain (thumb) which contains the catalytic triad.  The 
structure also resolved an N-terminal addition to the papain-like fold that was structurally 
similar to the ubiquitin-like (Ubl) domains of both the herpes-associated ubiquitin-
specific protease (HAUSP) and ubiquitin-specific protease 14 (USP14) (Ratia et al., 
2006; Sulea et al., 2006).  Interestingly, the substrate specificity of SARS-CoV PLpro 
(P4-LXGG-P1), which is shared by many coronavirus PLP2 enzymes, is also common to 
many deubiquitinating enzymes (Barretto et al., 2005).  As predicted, both SARS-CoV 
PLpro and MHV PLP2 have been shown to possess deubiquitinating activity (Barretto et 
al., 2005; Lindner et al., 2005; Zheng et al., 2008).  Thus, it is possible that coronavirus  
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Fig. 1.5.  Structure of SARS-CoV PLpro.  A) The structure of SARS-CoV PLpro is 
shown, with secondary structure depicted by ribbons.  The four domains are shown by 
color.  B) The domains are shown outlined in boxes and labeled: Yellow: zinc ribbon 
domain (finger), with coordinating residues highlighted as ball-and-stick representations.  
C) Rotation of the molecule displays the protease substrate pocket and the tetrahedral 
zinc-coordinating loops.  Red: b-sheet domain of the papain-like fold (palm), with 
catalytic residues His and Asp highlighted.  Green: a-sheet domain of the papain-like fold 
(thumb), with catalytic Cys highlighted.  Blue: Ubiquitin-like domain (Ubl).  Structure 
was retrieved from the PBD database (PDB ID: 2FE8) and modified using iMol 
(www.pirx.com/imol).  Images provided by R. Graham. 
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PLP2-like enzymes deubiquitinate either viral or cellular proteins to promote virus 
replication. 
 Consistent with the coronavirus PLP2-like enzymes having a restricted substrate 
specificity, modeling revealed that the active site is only accessible by substrates with 
small amino acid side chains, preferably glycine residues, in the two positions upstream 
of the CS.  In contrast, modeling of PLP1-like enzymes suggests a more open 
conformation of the substrate binding pocket than that of PLP2-like enzymes, in which 
substrates have either a P2 Arg or a Cys followed by a small P1 amino acid directly 
upstream of the CS (Sulea et al., 2006).  While the catalytic inactivation of some PLP1-
like enzymes has resulted in the recovery of infectious virus, the catalytic inactivation of 
PLP2-like enzymes has not been reported or failed to produce infectious virus, suggesting 
that the catalytic activity of PLP2 is required for virus replication (Graham and Denison, 
2006; Ziebuhr et al., 2007). 
 
Coronavirus replication complexes 
 All viruses utilize strategies that allow for modification of host cells to generate 
an environment that is suitable for the production of progeny virions.  Positive-sense 
RNA viruses modify intracellular membranes to support viral RNA synthesis.  These 
membrane modifications are made up of viral replicase proteins, cellular proteins, and 
cellular membranes that assemble into what are termed replication complexes, which are 
the sites of viral RNA synthesis.  For coronaviruses, virus-induced membrane 
modifications result in the formation of convoluted membranes (CMs) and double 
membrane vesicles (DMVs), both of which are not present in uninfected cells (Knoops et 
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al., 2008).  While nsps localize to both of these structures, only DMVs have been 
implicated in viral RNA synthesis (Goldsmith et al., 2004; Gosert et al., 2002).  
Coronavirus-induced DMVs accumulate over the course of virus infection and range in 
size from 200 to 350 nm in diameter.  In situ hybridization with riboprobes that detect 
viral RNA revealed co-localization of DMVs and viral RNA (Goldsmith et al., 2004; 
Gosert et al., 2002).  Moreover, Immuno-EM analyses have shown that newly 
synthesized viral RNA associates with DMVs (Goldsmith et al., 2004; Gosert et al., 
2002; Knoops et al., 2008; Snijder et al., 2006).  Thus, it is presumed that virus-induced 
DMVs are the sites of coronavirus RNA synthesis.  
 In addition to products of the coronavirus replicase mediating direct roles in viral 
RNA synthesis, some nsps are hypothesized to play essential functions in the formation, 
organization, and stability of virus-induced membrane modifications.  A common feature 
of the replicase from all coronaviruses is the characteristic transmembrane regions 
encoded in ORF1a.  Bioinformatic analyses of the coronavirus replicase reveals that nsps 
3, 4, and 6 contain predicted transmembrane domains.  These transmembrane domains 
are thought to be essential for modification of cellular membranes and association of 
replicase proteins with replication complexes.  Because nsps 3, 4, and 6 all contain 
predicted transmembrane domains, they are the most likely candidates for inducing 
membrane rearrangements and environments that are suitable for RNA synthesis.  These 
proteins were first predicted to be replicase anchor proteins based on the long stretches of 
hydrophobic residues in their amino acid sequences (Lee et al., 1991).  Membrane 
topology studies have shown that nsp3, nsp4, and nsp6 all exhibit integral membrane 
characteristics (Baliji et al., 2009; Kanjanahaluethai et al., 2007; Oostra et al., 2007).   
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Fig. 1.6.  Coronavirus-induced membrane structures.  Top:  Electron tomographic 
image showing double membrane vesicles (DMVs) and convoluted membranes (CMs) 
of SARS-CoV infected cells.  Bottom left:  EM image of a mock-infected mouse 
embryonic stem cell.  No CMs or DMVs are detected.  Bar represents 500 nm.  Mit, 
mitochondria.  RER, rough ER.  Bottom right:  EM image of an MHV-infected mouse 
embryonic stem cell.  Bar represents 250 nm.  Images adapted from Knoops et al., 2008 
and J. Sparks, unpublished. 
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However, it is currently unknown if and how these proteins induce the membrane 
modifications that are observed during coronavirus infection. 
 
Coronavirus RNA synthesis 
 As members of the Nidovirales order, coronaviruses generate not only new 
genome RNA, but also a 3’-nested set of subgenomic RNAs that each contains the first 
approximately 70 nucleotides of the 5’ leader sequence of the genome.  Because these 
viruses produce two distinct forms of RNA, coronavirus RNA synthesis can be visioned 
as having two distinct processes.  In the first process, the positive-sense genome RNA is 
transcribed into a negative-sense template RNA complementary to the genome.  The 
negative-sense RNAs are then used as templates for synthesis of new positive-sense 
RNAs during genome replication of viral RNA synthesis.  In the second process, 3’-
nested subgenomic RNAs (sgRNAs) are transcribed to serve as templates for translation 
of the viral structural and accessory proteins.  While the transcription process of viral 
RNA synthesis is poorly understood, evidence is consistent with a discontinuous model 
of RNA transcription (Pasternak, Spaan, and Snijder, 2006; Sawicki and Sawicki, 1990; 
Sawicki and Sawicki, 1998; Sawicki and Sawicki, 2005).  It is not known whether these 
two different processes can occur simultaneously or if they compete with each other 
during RNA synthesis. 
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Fig. 1.7.  Coronavirus genome replication and subgenomic RNA transcription.  Coronavirus RNA 
synthesis, as outlined above, can be conceptualized as involving two stages.  A) In the first stage, the 
positive-sense genome RNA (+ genome) is transcribed into a negative-sense template RNA (- genome), 
and then positive-sense genome RNAs are synthesized from negative-sense templates in the genome 
replication stage.  B) In the second stage, 3’-nested subgenomic RNAs are transcribed to serve as 
templates for translation of the viral structural and accessory proteins.  This second stage of viral RNA 
synthesis is poorly understood, but it is thought to involve a discontinuous RNA transcription model.  
During negative strand synthesis, the viral RNA-dependent RNA polymerase recognizes virus-specific 
conserved sequences termed transcriptional regulatory sequences (TRSs), located just upstream of each 
subgenomic open reading frame.  At these locations, the polymerase either reads through to the next 
TRS or dissociates from the template strand, then reassociates with the leader TRS, located in the 5’ 
UTR, and completes transcription, resulting in the production of subgenomic RNAs that are 3’-
coterminal, and that all possess a 5’ leader sequence.  Figure adapted from Sawicki and Sawicki, 2005. 
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 Before RNA synthesis occurs, ORF1 of the genome RNA must be translated into 
the replicase polyproteins.  The genome RNA also acts as the template for synthesis of 
negative-sense RNA.  In the discontinuous model of RNA transcription, RNA synthesis 
events produce a series of shorter, sgRNAs of both positive and negative polarity (Baric 
and Yount, 2000; Sethna, Hofmann, and Brian, 1991; Sethna, Hung, and Brian, 1989).  
The viral RNA synthesis machinery, including replicase proteins such as the RNA-
dependent RNA polymerase, recognizes virus-specific transcriptional regulatory 
sequences (TRSs), located directly upstream of each subgenomic ORF.  Upon 
encountering a TRS, the RNA-dependent RNA polymerase either transcribes through the 
TRS or dissociates from the template strand and reassociates with the leader TRS located 
in the 5’ untranslated region (UTR) of another genome template.  After the template 
switching, transcription reinitiates and results in the production of a nested set of  
negative-sense sgRNAs that are then transcribed into 3’-coterminal positive strand 
subgenomic mRNAs, all of which contain an identical 5’ leader sequence.  The specific 
mechanism of template dissociation and template switching by the polymerase is not well 
understood, but it is thought to be mediated by complementary binding of the nascent 
subgenomic TRS with the leader template TRS.  Reports have implicated an approximate 
8 nucleotide core consensus TRS and nucleotides immediately 5’ and 3’ of this core 
sequence in the efficiency of sgRNA transcription (Curtis et al., 2004; Sola et al., 2005). 
 
Coronavirus reverse genetics 
 Over the past decade, several approaches have proven to be successful for reverse 
genetic studies of coronaviruses.  One method, termed targeted recombination, takes 
 27 
advantage of the virus’s natural ability to homologously recombine for introduction of 
mutations into the virus via recombination with a non-infectious construct (Masters et al., 
1994).  This system has been quite useful for study of the viral genome from the Spike 
gene to the 3’ end of the genome, but it has not been useful for studies of ORF1.  Within 
the last few years, several groups have developed alternative strategies that enable 
reverse genetic manipulation of entire coronavirus genomes.  A bacterial artificial 
chromosome full-length cDNA system has been developed for transmissible 
gastroenteritis virus (TGEV) studies (Almazan et al., 2000; Gonzalez et al., 2001; 
Gonzalez et al., 2002), and vaccinia virus-driven full-length cDNA expression systems 
are available for HCoV-229E, MHV, and IBV (Casais et al., 2001; Coley et al., 2005; 
Thiel et al., 2001; Thiel and Siddell, 2005).  Additionally, cDNA cassette-based 
constructs have been designed for studies of TGEV, MHV, SARS-CoV, and IBV (Youn, 
Leibowitz, and Collisson, 2005; Yount, 2000; Yount et al., 2003; Yount et al., 2002).  
 In the MHV reverse genetic system used in this research, the complete genome is 
maintained as separately cloned cDNA fragments.  Mutations can be engineered into 
individual fragments at this stage.  To assess the effects of a particular mutation, or 
mutations, in the context of the virus, the cDNA fragments are cut by restriction 
enzymes, ligated together in vitro, transcribed using an incorporated T7 phage promoter, 
and transfected as infectious, full-length genomic RNA into replication-permissive cells.  
If the introduced mutations do not render the genome replication-incompetent, virus can 
then be harvested from the cell supernatant.  The Denison laboratory has used this 
cassette-based reverse genetics system for both MHV and SARS-CoV with great success.  
This dissertation will describe multiple mutant viruses generated by this system. 
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Fig. 1.8.  MHV cassette-based cDNA reverse genetics system.  A representative schematic of the 
MHV system is shown.  The MHV genomic RNA (black bar) was reverse transcribed and maintained 
as independent, plasmid-based cDNA cassettes.  Mutations are made at this stage.  MHV fragments 
(colored rectangles) are then digested from the parental plasmids using specific restriction enzymes 
and ligated together by unique restriction overhangs.  RNA is in vitro transcribed from an 
incorporated T7 promoter (yellow triangle) at the 5’ end of the first MHV cDNA fragment and 
subsequently electroporated into permissive cells.  Virus can be harvested from the cell supernatant 
24-48 hours post infection. Adapted from Yount et al., 2002. 
 
 29 
Summary 
 Despite many years of research from multiple investigators, the many details of 
the mechanisms by which coronaviruses replicate and cause disease remain to be defined.  
With the invention of coronavirus reverse genetics systems, major advances have been 
made in defining functions and requirements for those functions of several coronavirus 
nsps.  Previous research in the Denison Laboratory has focused on the cell biology and 
replication of coronaviruses.  My research has focused on both of these areas.  
 Prior to my dissertation research, MHV nsp2 was shown to be nonessential for 
virus replication, but deletion of the nsp2 coding sequence from the genome resulted in 
reduced growth and RNA synthesis.   These findings led to several important questions 
that my research aimed to address.  These questions included: Can nsp2 be expressed 
from alternative locations in the genome?  If so, is natively expressed nsp2 required for 
optimal replication?  Does nsp2 expressed from alternate locations affect its function and 
localization?   
 The findings from this research and previous work from the Denison lab led to the 
investigation of interactions between PLPs and CSs.  Our lab has shown that PLP-
mediated processing of nsps 1-3 is required for optimal replication of MHV, but that 
catalytic activity of PLP1 is not required for virus replication in culture.  Part of my 
graduate research aimed at extending these studies to address:  What are the determinants 
of PLP-mediated processing of nsps 1-3 in the context of replicase polyprotein 
expression?  What are the requirements for encoding one or two PLPs?  Can PLP 
specificity, the recognition and processing of a CS, be switched by altering the CS amino 
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acid sequence?  Are there additional determinants that are critical for PLP recognition 
and processing? 
 Lastly, other work from our laboratory has studied the role nsp4 plays in virus 
replication and replication complex function.  This study demonstrated MHV nsp4 is 
essential for recovery of infectious virus and identified important residues and domains of 
nsp4.  It is also predicted that nsp4 plays a role in the formation and organization of 
replication complexes.  My research aimed to address the following questions.  Is nsp4 
glycosylated when expressed from its native genomic location?  What effect does nsp4 
glycosylation have on virus replication?  Does nsp4 regulate virus-induced membrane 
modifications?   
 Understanding and studying the functions of coronavirus nsps 1-4 and their 
processing during virus replication is important for several reasons.  These reasons are:  
(1) PLP-mediated processing regulates the expression and functions of nsps 1-4; (2) 
although there is considerable sequence diversity, evidence suggests that coronavirus 
nsps 1-4 have similar functions in their respective life cycles; (3) because nsps 1-4 are the 
first to be expressed in an infected cell, these nsps are critical in creating a suitable 
environment that supports early steps in the coronavirus life cycle.  Therefore, by 
elucidating the mechanisms and requirements of coronavirus PLP-mediated processing 
and functions of the cleavage products in virus replication, the results will contribute to 
our knowledge of coronavirus evolution and how coronavirus replication occurs inside 
host cells. 
  
 31 
CHAPTER II 
 
MHV MUTANT VIRUSES ENCODING NSP2 AT DIFFERENT GENOMIC LOCI 
HAVE ALTERED REPLICATION, PROTEIN EXPRESSION, AND LOCALIZATION 
 
Introduction 
Positive-sense RNA viruses express polyproteins from their genomic RNA that 
are proteolytically processed by viral and cellular proteases to yield nonstructural, 
structural, or both types of proteins.  To understand the functions of particular 
polyproteins and mature proteins of positive-sense RNA viruses, several studies have 
reported the effects of protein domain deletions in virus replication.  Additionally, there 
had been no published reports showing deletions of entire mature proteins allowed for 
virus replication of any positive-sense RNA virus until work from the Denison lab 
reported that the entire coding region of MHV nsp2 and SARS-CoV nsp2 could be 
deleted from their respective genomes. 
The murine hepatitis virus (MHV) nsp2 is a 65-kDa protein that has minimal 
sequence identity or similarity among different coronavirus groups and has no known or 
predicted functions.  Research from the lab has shown for MHV and SARS-CoV that in-
frame deletion of nsp2 (Δnsp2) yields viable mutant viruses (Graham et al., 2005); 
however, both MHV and SARS-CoV Δnsp2 mutants exhibit a 90% reduction in peak titer 
and a 50% reduction in viral RNA synthesis.   
To determine if expression of nsp2 from non-native sites in the genome could 
complement the defect in MHV Δnsp2 replication and to gain a better understanding of 
nsp2 function, the nsp2 coding sequence was engineered at alternative sites in the 
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genome, both in the absence and presence of the wild-type ORF1a nsp2 sequence.  The 
results indicate that nsp2 can be encoded and expressed alone from ORF4, as a sequence 
duplication in ORF1a and ORF1b or in ORF1a and ORF4, but not near the end of ORF1a 
or alone in ORF1b.  Duplication of the nsp2 sequence or expression from ORF4 was 
detrimental to replication compared to wild-type, indicating that the native context of 
nsp2 expression, and possibly a single copy of the sequence, may be necessary for 
optimal function in replication.  Results also indicate that addition of amino acids at the 
N- and C- termini of natively expressed nsp2 have no effect on peak viral growth.  
Mutations at the C-terminus of nsp2 resulted in delays in exponential growth, indicating 
that the timing of processing of natively expressed nsp2 from the replicase polyprotein is 
required for optimal replication. 
  
Nsp2 can be encoded at different locations in the  
coronavirus genome and still allow for virus replication 
 MHV nonessential ORFs have been shown to tolerate foreign gene insertion (de 
Haan et al., 2005; Fischer et al., 1997; Oostra et al., 2007).  In order to test the effects of 
nsp2 expression in downstream ORFs, the mutant MHV genome was engineered to have 
the substitution of the nsp2 coding sequence in place of the nonessential ORF4 coding 
sequence, while retaining the ORF4 transcriptional regulatory sequence (5’-CUAAAC-
3’) and start codon (Fig. 2.1 and Table 2.1).  To determine if nsp2 could be expressed 
from alternate locations in the replicase, the nsp2 sequence was engineered at the end of 
ORF1a following nsp10 (nsp10-11 and nsp10-12 junction) and in ORF1b between nsp13 
and nsp14.  Since processing between nsp10-12 and nsp13-14 is mediated by nsp5 
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(3CLpro), minimal 3CLpro-recognition cleavage sites of P2-LeuGln↓Ser-P1’ (Lu, Sims, 
and Denison, 1998b; Pinon, Teng, and Weiss, 1999; Ziebuhr and Siddell, 1999) were 
introduced at the amino and carboxy termini of nsp2 by the addition of a Ser residue to 
the N-terminus of nsp2 and LeuGln residues to its C-terminus, leaving the 3CLpro 
recognition sequences of nsp10, nsp12, nsp13, and nsp14 intact.  The wild-type N-
terminal nsp2 residue is Val; Ser was selected as a conservative addition that would 
optimize for cleavage by nsp5.  The lab has previously shown that P1’ substitutions at the 
amino-terminus of nsp2 that allow processing (Ala, His) do not affect virus growth or 
RNA synthesis (7); however, to determine if Ser and LeuGln additions had any effects on 
nsp2 functions from alternately expressed nsp2 viruses, these mutations were engineered 
into natively expressed nsp2 in a wild-type virus background. 
Infectious viruses were recovered from supernatants of electroporated cells for: 
ORF4 deletion, with or without ORF1a-nsp2 expression (1a-2/Δ4 and Δ1a-2/Δ4); ORF4-
nsp2, with or without ORF1a-nsp2 expression (1a-2/4-2 and Δ1a-2/4-2); ORF1b-nsp2 
with ORF1a-nsp2 expression (1a-2/13-2-14); and ORF1a-nsp2 with amino acid additions 
at the N- and/or C-termini (1a-S2, 1a-2LQ, and 1a-S2LQ).  The supernatants from 
electroporated cells were passaged to expand the populations (passage 1 [P1]), and RNA 
from cells infected with P1 virus stocks was used to confirm the retention of all 
engineered changes from recovered mutants.  Multiple attempts to recover mutants 
lacking ORF1a-nsp2 but expressing nsp2 in ORF1b (Δ1a-2/13-2-14) failed to produce 
infectious virus.  Recovery attempts were also unsuccessful for mutants encoding nsp2 
in-frame between nsp10-nsp12, with or without ORF1a nsp2 expression (1a-2/10-2-
12 and Δ1a-2/10-2-12).  
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Fig. 2.1.  Engineering nsp2 deletions, mutations, rearrangements, and duplications.  For each 
construct, alterations to the genome are shown.  Constructs are listed as named in the text.  Open 
reading frames (ORFs) 1-7 are labeled above the wild-type schematic.  The nsp2 coding sequence is 
depicted as a hatched rectangle.  Coding region locations and sizes are not drawn to scale.  Deletion 
of the nsp2 and/or ORF4 coding sequences or insertion of nsp2 in ORF1b is indicated by a caret.  
Protein coding deletions are indicated by a delta (Δ) in the virus name.  Nsp2 position is indicated as: 
ORF1a (1a-2), ORF1b (13-2-14 or 10-2-12), or ORF 4 (4-2).  Approximate peak titers of viable 
viruses are indicated to the right of each construct.  Viruses that were not recovered are indicated by a 
minus sign (-). 
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Protein expression and processing from 
nsp2 alternate expression and duplication viruses 
 To determine the expression and processing of nsp2 in mutant virus infections, 
lysates of radiolabeled, virus-infected DBT cells were immunoprecipitated with antisera 
against nsp1, nsp2, and nsp3 (Fig. 2.2A).  Mature nsp1 (28 kDa) was detected in all 
mutant virus-infected cells, demonstrating normal processing between nsp1 and nsp2 by 
the nsp3 papain-like proteinase 1 (PLP1).  Mutant viruses that expressed nsp2 from 
ORF1a (1a-2/Δ4, 1a-2/13-2-14, and 1a-2/4-2) and the Δnsp2 virus (Δ1a-2) all produced 
similar amounts of nsp1 relative to wild-type, while the Δ1a-2/Δ4 and Δ1a-2/4-2 viruses 
expressed lower levels of nsp1.  Nsp3 was detectable with α−nsp3 in wild-type-infected 
cells as both mature nsp3 (210 kDa) and intermediate nsp2-3 (275 kDa).  Mutant viruses 
that encoded nsp2 in its native position (1a-2/Δ4, 1a-2/4-2, and 1a-2/13-2-14) also had 
detectable nsp3 and nsp2-3.  Only mature nsp3 was detected in infections with viruses 
that lacked ORF1a-expressed nsp2 (Δ1a-2, Δ1a-2/Δ4, and Δ1a-2/4-2).   
As expected, mutant viruses that did not encode nsp2 at any location (Δ1a-2 and 
Δ1a-2/Δ4) had no detectable nsp2.  Viruses encoding nsp2 from one or two locations in 
the genome exhibited a range of nsp2 expression levels.  The Δ1a-2/4-2 virus expressed 
low levels of nsp2, while the 1a-2/Δ4 mutant virus expressed nsp2 expression levels 
similar to wild-type.  The 1a-2/4-2 duplication mutant, which encoded nsp2 in both 
ORF1a and ORF4, expressed higher levels of nsp2 compared to wild-type virus.  To test 
whether the increased expression was due to just two coding locations or if there was also 
altered levels of ORF4 subgenomic RNA, infected cells were labeled with [3H]-uridine in 
the presesnce of Actinomycin D, and viral RNAs were measured by densitometry using 
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ImageJ 1.40 (Rasband, 1997-2008) (Fig. 2.2B).  All genomic and subgenomic RNA 
species were detected, but RNA4 encoding nsp2 in ORF4 in the 1a-2/4-2 virus was 
expressed with a 2.5 fold increase, as a ratio to RNA7, compared to wild-type virus.  This 
is sufficient to account for the increased nsp2 levels and suggests that insertion of foreign 
genes in ORF4 may specifically alter mRNA transcription.     
The 1a-2/13-2-14 mutant virus, which encoded nsp2 in both ORF1a and ORF1b, 
expressed overall levels of mature nsp2 that were comparable to wild-type.  This could 
have resulted from either diminished translation from ORF1b or impaired or absent 
processing.  The requirement for in-frame translation of nsp13 and nsp14 for virus 
viability argues that the in-frame nsp2 must be translated from this location in ORF1b. 
The efficiency of ribosomal frameshifting and translation of ORF1b relative to ORF1a 
has not been experimentally tested during virus infection, but is predicted to be less than 
25% (Brierley, 1989).  This would be consistent with the detection of minimal additional 
nsp2.  The lack of detection would also result if expressed nsp2 was not cleaved from 
nsp13, nsp14, or both, and thus was not detected as mature nsp2.  Also, 
immunoprecipitation with α−nsp2 or α−nsp13 antisera did not resolve precursors 
consistent with a predicted size for nsp13-2 (130 kDa), nsp2-14 (130 kDa) or nsp13-2-14 
(190 kDa).  Taken together, these data indicate that levels of protein expression depend 
on a combination of the number of coding sequence copies and the context of expression.  
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Fig. 2.2.  Protein expression, processing, and RNA synthesis of altered nsp2 viruses.  DBT cells 
were infected with viruses as indicated above the gels.  A) Proteins were radiolabeled, and cell lysates 
were immunoprecipated with α-nsp1, α-nsp2, and α-nsp3 antibodies. Mock indicates mock-infected 
cells and wt indicates recombinant wild-type MHV-A59.  Nsps are indicated to the right of the gel: nsp2-
3 (275 kDa), nsp3 (210 kDa), nsp2 (65 kDa), and nsp1 (28 kDa).  B) Viral RNA was metabolically 
labeled with [3H]-uridine in the presence of Actinomycin D from 9 to 11 h p.i.  Intracellular RNA was 
isolated, denatured, and resolved by electrophoresis.  Genomic RNA (R1) and subgenomic mRNAs (R2 
to R7) are indicated.  R2, R3, and R4 from the 1a-2/∆4 virus are approximately 300 base pairs (bp) 
shorter than wild-type mRNAs and are indicated by a †.  The 1a-2/∆4 virus was used as a control in 
which ORF4 is deleted, but its transcriptional regulatory sequence is still present, resulting in R4 co-
migrating with R5.  R2, R3, and R4 from the 1a-2/4-2 virus, which are approximately 1400 bp longer 
than wild-type R2, R3, and R4, are indicated with an *.  An unknown band, possibly an R4 degradation 
product, is indicated by a ^.  R1 from wild-type and mutant viruses exhibited some variability in 
migration.  This variability is supported by quantification of overall genomic RNA levels (1a-2/∆4 > wt 
> 1a-2/4-2).  RNA band sizes and quantification were determined by using ImageJ 1.40. 
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Localization of nsp2 in cells during infection with mutant viruses 
 To determine if nsp2 localization was affected by genomic location and extent of 
expression, DBT cells were infected, and at 6 hours post-infection (h p.i.), cells were 
fixed and stained with antibodies against nsp2 and nsp8, both markers for replication 
complexes (Bost, Prentice, and Denison, 2001) (Fig. 2.3).  Nsp2 and nsp8 signals co-
localized in characteristic cytoplasmic perinuclear foci in cells infected with viruses 
expressing both nsp2 and nsp8 (wt, 1a-2/Δ4, and Δ1a-2/4-2).  When expression of nsp2 
was absent (Δ1a-2/Δ4), no nsp2 signal was present, while nsp8 signal was still detected in 
punctate foci.  Nsp2 expressed from the 1a-2/4-2 virus showed partial co-localization 
with nsp8 signal, but nsp2 was also detected as diffuse cytoplasmic fluorescence that was 
not associated with punctate foci.  A possible explanation for this result is that 
simultaneous expression of nsp2 from ORF1 and ORF4 in the 1a-2/4-2 virus saturates 
replication complexes.  This would be consistent with the observed increase in nsp2 
expression (Fig. 2.2A).  This conclusion is also supported by the observation that 
infection with the 1a-2/13-2-14 mutant, which resulted in lower levels of mature nsp2 
(Fig. 2.2A), showed co-localization of nsp2 with nsp8, but no additional localization or 
diffuse fluorescence (Fig. 2.3).  While direct proof of differential localization of nsp2 
would require unique tags for nsp2 at different loci, it is still clear that alteration of the 
nsp2 coding location within the genome results in differences in both the extent of protein 
expression and localization of nsp2 during infection.  
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Fig. 2.3.  Immunofluorescence of nsp2 mutants.  DBT cells on glass coverslips were infected for 
6 h, fixed, and stained for nsp2 and nsp8 by Alexa546 conjugated to a secondary IgG antibody and 
Alexa488 directly conjugated to a primary IgG antibody, respectively.  Co-localization is indicated 
by yellow pixels in the merged images.  The bar in the upper right image equals 20 µm and is 
representative for all images. Images were obtained on a Zeiss LSM510 and were processed in 
Adobe Photoshop CS2. 
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Nsp2 encoded at different locations results in varied effects on growth 
 To assess the effects of alternate nsp2 encoding on virus replication, DBT cells 
were infected at a multiplicity of infection (MOI)=1 PFU/cell, aliquots of supernatant 
were saved, and virus was titered by plaque assay (Fig. 2.4).  As previously shown 
(Fischer et al., 1997), deletion of ORF4 resulted in a mutant virus that had growth 
kinetics and peak titers indistinguishable from wild-type (Fig. 2.4A).  Deletion of nsp2 
alone (Δ1a-2) resulted in a decrease of ~1 log10 compared to wild-type, also consistent 
with previous studies (11).  Expression of nsp2 from ORF4 in the presence or absence of 
ORF1a nsp2 was similar to the parental Δ1a-2 mutant in the timing of exponential 
growth.  However, the 1a-2/4-2 mutant virus reached slightly higher titer than the Δ1a-2 
virus but did not achieve wild-type growth in 24 h p.i. (Fig. 2.4B), suggesting that 
increased total levels of nsp2 expression may in fact be detrimental to virus growth 
fitness.  Also, the Δ1a-2/4-2 virus achieved a 0.5-log10 lower peak titer than Δ1a-2, and 
titer declined more rapidly than that of either Δ1a-2 or 1a-2/4-2 over a 24h period.  The 
results show that ORF4 expression of nsp2 does not complement the deletion of nsp2 
from ORF1a and suggest that ORF4 expression of nsp2 in the absence of ORF1a nsp2 
expression results in a less fit mutant virus.  Similar to the 1a-2/4-2 virus, when nsp2 was 
expressed in ORF1b (1a-2/13-2-14), growth was delayed in timing and peak titer could 
not reach that of wild-type virus at 24 h p.i., even though peak titers were still increasing, 
similar to the 1a-2/4-2 virus (Fig. 2.4B).   
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Fig. 2.4.  Growth of nsp2 alternate expression viruses.  DBT cells were infected with indicated 
viruses at a multiplicity of infection (MOI) = 1 plaque forming unit (PFU) per cell.  Aliquots of 
supernatant were taken at indicated times p.i. and titered by plaque assay.  All infections were 
performed in the same experiment with replicates.  A) Nsp2 and ORF4 deletion and ORF4 single 
expression mutants.  B) Nsp2 duplication viruses.  Wild-type curve and Δ1a-2 curve from A are 
duplicated in B to allow direct comparison.  
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 It was also surprising to see that deletion of both nsp2 and ORF4 or nsp2 
replacement of ORF4 (Δ1a-2/Δ4 and Δ1a-2/4-2) yielded mutants with more delayed 
and/or decreased growth than deletion of either nsp2 or ORF4 alone (Fig. 2.4A).  These 
results suggest possible interactions and/or cooperative functions of nsp2 and the ORF4 
protein(s) in the virus life cycle.  Both nsp2 and the ORF4 gene product(s) are group-
specific proteins (de Vries et al., 1997; Masters, 2006; Ziebuhr, Thiel, and Gorbalenya, 
2001) and may have, as of yet, uncharacterized interactions.  Alternatively, it is possible 
that the known replication defect of the Δnsp2 mutant exacerbates a replication defect in 
an ORF4 deletion mutant that alone does not manifest as a change in growth kinetics in 
cell culture.  Finally, it is possible that altered RNA folding or protein-RNA interactions 
resulting from the cumulative deletion of >2kb of genome is responsible for the observed 
replication defect and decrease in expression of nsps 1-3.  This possibility is supported by 
the result that 1a-2/4-2 virus had a slight growth delay, grew to peak titers >1 log10 higher 
than Δ1a-2/Δ4, and exhibited higher expression levels of nsps 1-3.  
 
Additions of amino acids at the N- and/or C-termini  
of nsp2 affect protein processing but not peak virus growth 
Because alternately expressed nsp2 was engineered to contain minimal 3CLpro 
cleavage sites (P2-LeuGln↓Ser-P1’) when introduced between nsp13 and nsp14 to 
promote cleavage, I next wanted to determine the effects on virus growth by introducing 
amino acids at the N- and C-termini of nsp2.  Therefore, viruses were engineered to have 
addition of a Ser residue at the N-terminus (1a-S2), LeuGln residues at the C-terminus 
(1a-2LQ), or both mutations (1a-S2LQ) in the native location of nsp2 (Fig. 2.1 and Table 
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2.1).  Virus growth experiments were performed as previously described at an MOI=0.1 
PFU/cell, and the 1a-S2, 1a-2LQ, and 1a-S2LQ viruses reached peak growth similar to 
wild-type virus (Fig. 2.5A), suggesting that the additional amino acids do not inhibit 
function(s) of nsp2 in cell culture.  However, the 1a-2LQ and 1a-S2LQ viruses were 
slightly delayed in exponential growth compared to wild-type virus.  Protein processing 
experiments show detection of mature nsp2 in the 1a-2LQ and 1a-S2LQ viruses (Fig. 
2.5B), yet pulse-chase analysis reveals decreased expression of mature nsp2 over time in 
the 1a-2LQ and 1a-S2LQ viruses compared to wild-type virus (Fig. 2.5C).  These 
observations are consistent with the previously described ΔCS2 mutant virus, which has a 
delay in exponential growth, can reach peak titers similar to wild-type virus, and exhibits 
no mature nsp2 detection (Fig. 2.5A and 2.5B).  Therefore, the additions of amino acids 
at the N- and C- termini of nsp2 appear to be affecting processing and not the overall 
functions of nsp2.  Additionally, it is not known whether PLP1 or 3CLpro is mediating 
processing at the C-terminus of nsp2 that has been engineered to contain the minimal 
3CLpro cleavage site sequence.  Therefore, the delay in timing of exponential growth 
may be due to PLP1 being unable to process the C-terminus of nsp2, but rather, 3CLpro 
mediating processing at the engineered site.  This would be consistent with later 
expression of 3CLpro compared to PLP1, which may result in the delay of exponential 
growth  observed in the 1a-2LQ and 1aS2LQ mutant viruses. 
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Fig. 2.5.  Growth and protein processing of 1a-S2, 1a-2LQ, and 1a-S2LQ viruses. A) DBT 
cells were infected with indicated viruses at an MOI=0.1 PFU/cell.  Viral titers were determined as 
described above.  Infections were performed in the same experiment with replicates.  B) Protein 
processing experiments were performed as previously described.  Immunoprecipitations were 
performed with α-nsp1 and α-nsp2 antibodies.  All samples were resolved on the same gel, but the 
image was cropped to remove extraneous lanes.  C) Pulse-chase analysis was performed by 
infecting DBT cells at an MOI=10 PFU/cell.  Proteins were radiolabeled, and cell lysates were 
immunoprecipated with α-nsp1 and α-nsp2 antibodies.  Viruses are indicated to the left of the gels, 
and the time of chase (in minutes) is indicated at the top of the gels. 
 
 46 
Discussion 
 The results of this study demonstrate that it is possible for nsp2 to be encoded 
from alternate locations in the genome, either alone or in combination with ORF1a nsp2, 
and that alternate location or expression results in a range of effects on growth, 
expression, RNA synthesis, and localization.  Of interest, it was recently reported that an 
nsp2-EGFP fusion protein could be expressed from the nonessential MHV ORF2b 
(Verheije et al., 2008). Although the replication phenotype of this virus was not reported, 
the result is consistent with this study and indicates that additional sites of nsp2 
expression/duplication are tolerated.  In these experiments, the modest growth defect of 
an nsp2 deletion is not complemented by expression from ORF1b or ORF4, suggesting 
that whatever function nsp2 serves, the timing and/or interactions resulting from 
expression between nsp1 and nsp3 are likely critical for its role.  Specifically, it is known 
that nsp2 is detectable as an nsp2-3 intermediate and that abolition of processing of nsp2 
from nsp3 results in a prolonged eclipse phase, while abolition of processing between 
nsp1 and nsp2 results in diminished growth (Denison et al., 2004; Graham and Denison, 
2006). This was consistent with the observation that addition of amino acids to the N-
terminus had no effect on processing and had wild-type growth, while addition of 
residues to the C-terminus of nsp2 altered processing and eclipse phase, but not peak 
viral growth.  Thus, the results suggest nsp2 may serve as an important cis regulatory 
protein for nsp1 and nsp3.  The results also indicate that protein processing is also a 
determinant of nsp2 and/or nsp3 function(s). 
This report also demonstrates that the expression of nsp2 from alternate locations 
in the genome has no effect on its recruitment to replication complexes.  However, 
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encoding nsp2 at both its native location and in place of ORF4 resulted in overexpression 
of nsp2 and altered its localization.  Although nsp2 still localized to replication 
complexes, overexpression of nsp2 also resulted in nsp2 to be detected as diffuse 
fluorescence throughout the cytoplasm of infected cells, suggesting that it is possible to 
saturate replication complexes with nsp2 and potentially other nsps.   
Since nsp2 is dispensable for replication, the results presented here cannot directly 
predict the rearrangement effects of essential replication proteins, such as nsp5 (3CLpro) 
or nsp12 (RdRp).  However, these results have shown that additional protein sequence 
can be encoded not only in the downstream ORFs but also in the replicase between nsp13 
and nsp14, suggesting flexibility in both ORF1a and ORF1b for deletion, introduction, 
and reordering of protein domains.  Demonstration that an ORF1 protein can be 
expressed from alternate locations and can still target to replication complexes suggests 
that it will be possible to test the effects of alteration of location and extent of expression 
of critical replication proteins on virus viability, growth, and pathogenesis.  These future 
studies are further addressed in Chapter V. 
 
 48 
CHAPTER III 
 
REWIRING THE MURINE HEPATITIS VIRUS REPLICASE POLYPROTEIN TO 
FUNCTION WITH A SINGLE PAPAIN-LIKE PROTEASE 
 
Introduction 
 Before this project began, it was known that virus-encoded proteases of positive-
sense RNA viruses are important regulators of their respective life cycles (Ryan and 
Flint, 1997; Vasiljeva et al., 2003; Ziebuhr, Snijder, and Gorbalenya, 2000).  These 
specific proteases mediate co- and post-translational processing of large polyproteins, 
resulting in intermediate and mature proteins.  The processing events are spatially and 
temporally regulated, allowing for diverse and distinct functions of intermediate and 
mature proteins at different stages of the life cycles of these particular viruses.  While the 
cleavage site (CS) amino acid sequences and protease interactions have been identified 
and studied extensively in vitro, less is known about the requirements for processing in 
the context of complete polyprotein expression during virus replication.  These studies 
are critical for our understanding of how and why these processing events occur and will 
aid in the establishment of new approaches to interfere with protein processing and 
attenuate virus replication and pathogenicity. 
 For coronaviruses, the proteolytic processing of the replicase polyprotein is 
complex (Fig. 3.1A and 3.1B).  Protein processing occurs in a sequential fashion, and 
prior to the advent of coronavirus reverse genetics systems, it was not possible to study 
the roles of specific processing events on virus replication.  The first study from the 
Denison lab after the invention of the MHV reverse genetics system addressed the CS 
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amino acid requirements for processing between nsp1 and nsp2 at CS1.  This study 
showed that processing at CS1 was not required for virus replication; however, blocking 
cleavage, either by amino acid substitution or by deletion of the critical CS residues, of 
this processing event resulted in a decrease in virus growth, RNA synthesis, and 
cytopathic effect (Denison et al., 2004).  The lab next addressed whether processing at 
CS2 was required for infectious virus.  Deletion of CS2 resulted in viable virus with no 
decrease in peak virus titer, but did result in a delay in exponential growth.  Due to both 
CS mutations resulting in viable virus, a mutant genome with deletions of both CS1 and 
CS2 was generated, and viable virus was recovered.  This mutant virus displays no 
processing at the deleted CSs and manifests a reduction and delay in virus growth, 
exhibiting growth defects observed in both of the single CS deletion viruses. 
 Because CS1 and CS2 can be deleted and both are processed by PLP1, the 
protease activity of PLP1 was abolished, and this resulted in a virus that was severely 
impaired in growth.  Moreover, PLP2 did not process at CS1 or CS2 (Graham and 
Denison, 2006).  In contrast, ablation of PLP1 activity of HCoV-229E revealed that PLP2 
was capable of processing at CS1 and CS2 (Ziebuhr et al., 2007).  This outcome may be 
due to the fact that there is more similarity between CSs of  HCoV-229E than that of CSs 
1-3 of MHV (Fig. 3.1C).   Even though both PLP1 and PLP2 of HCoV-229E can process 
at CS1 and CS2, PLP2 exhibited less efficient processing at CS1 than that of PLP1 but 
more efficient processing at CS2 than that of PLP1, most likely due to the recognition of 
proximal CS amino acid sequences by the particular PLP.  Unlike MHV and HCoV-
229E, SARS-CoV PLpro processes at the first three CSs (Harcourt et al., 2004), all of 
which have a P4-LXGG-P1 amino acid motif.  Similar to SARS-CoV PLpro, MHV PLP2 
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Fig. 3.1.  MHV replicase organization and comparisons of coronavirus PLP-mediated 
processing.  (A) ORF1, or the replicase gene, encodes the replicase polyprotein which is translated 
into pp1a, or because of a -1 ribosomal frameshift pp1ab.  Pp1ab is processed into 16 mature nsps 
that are indicated by vertical lines and numbers.  Viral PLP domains are shown as boxes within 
nsp3, and 3CLpro (nsp5) is indicated as a black box.  Arrowheads and vertical lines represent 
cleavage sites.  PLP1 cleavage sites are linked in white, the PLP2 cleavage site is linked in gray, 
and the 3CLpro cleavage sites are linked in black.  (B) Organization of nsp1 to nsp4 is shown for 
coronaviruses representing the major groups (1, 2a, 2b, and 3).  PLPs are indicated by black boxes, 
and a hatched box indicates a catalytically inactive remnant of PLP1 from IBV.  Processing events 
that have been confirmed in vitro or during infection are indicated by arrows.  (C) The cleavage 
site amino acid sequences of the coronaviruses listed in panel B are shown from P6 to P1’ with the 
PLP predicted or responsible for processing shown in the right column.  The arrow indicates the 
cleavage site. 
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cleaves directly downstream of an LXGG amino acid motif.  Therefore, the observed 
variation in the number and activity of PLPs in processing of nsp1-4 is associated with 
predicted differences in PLP structure and predicted or known CS amino acid sequences.  
These associations in the number of encoded catalytically active PLPs, PLP structure, and 
CS amino acid sequences have not been tested mechanistically. 
 Modeling of different coronavirus PLP enzymes reveals two distinct classes 
(Sulea et al., 2006).  The “restricted” class consists of SARS-CoV PLpro, both HCoV-
229E PLP1 and PLP2, IBV PLP, and MHV PLP2.  These enzymes are restricted in their 
substrate specificity and only recognize a small subset of amino acid sequences, with 
conservation of glycine or alanine in the two positions directly upstream of the peptide 
cleavage site (CS)(Harcourt et al., 2004; Herold et al., 1998; Lim and Liu, 1998; Lim, 
Ng, and Liu, 2000; Thiel et al., 2003).  The “open” class consists of mainly coronavirus 
group 2a PLP1 enzymes and recognizes a wider array of substrate amino acid sequences, 
with a conserved small amino acid residue directly upstream of the CS (Bonilla et al., 
1995; Bonilla, Hughes, and Weiss, 1997; Dong and Baker, 1994; Hughes, Bonilla, and 
Weiss, 1995; Schiller, Kanjanahaluethai, and Baker, 1998).  Bioinformatics suggests that 
PLP specificity, the recognition, binding, and processing of a cleavage site (CS) by a 
protease, is controlled primarily by amino acids directly upstream of the CS (Sulea et al., 
2006).  In coronaviruses that possess only one PLP or two restricted-class PLPs, the 
predicted or confirmed CS amino acid sequences are highly conserved between all CSs 
recognized by the PLP(s).  This is consistent with SARS-CoV PLP-mediated processing 
and the report from HCoV-229E in that PLP2 was capable of processing CS1 and CS2.  
In coronaviruses, such as murine hepatitis virus (MHV), that possess both open and 
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restricted forms of PLPs, CS amino acid sequences are divergent across the CSs, 
consistent with the report above in which PLP2 was not capable of processing the more 
divergent CS amino acid sequences of CS1 and CS2.  Therefore, it is predicted that only 
one PLP is necessary to process three CSs that are highly conserved, while two PLPs are 
necessary for processing at multiple divergent CSs.  However, it is unknown if proximal 
CS amino acid sequences are sufficient for PLP-mediated processing and if protease 
recognition and processing can be switched by altering CSs. 
 In the previous work from the Denison lab and Chapter II, amino acid 
substitutions at CS1 and CS2 were tested to determine the amino acid requirements for 
PLP1-mediated processing at the specific CSs.  Because there is flexibility in processing 
at the CS amino acid sequences and the number of PLPs varies among coronaviruses, the 
next area of investigation that was addressed examined the role of CS/PLP interactions.  
Particularly, this study sought to determine the effect of encoding one or two catalytically 
active PLPs, investigate the requirements for CS recognition and processing by PLPs, and 
test whether protease specificity could be switched by substitution of CS amino acid 
sequences.  Replacement of the MHV PLP1 “open” P4-P1 amino acid sequence of CS1 
and/or CS2 with the “closed” PLP P4-P1 LKGG sequence from MHV CS3 was 
introduced in the presence of an active or inactive PLP1.  Mutant viruses were recovered 
with altered protein processing and a range in growth from WT to highly impaired. 
Substitution of CS3 at CS2 was sufficient for a switch in protease specificity and allowed 
processing by PLP2, resulting in a virus capable of WT replication in culture.  While 
there was processing at CS2 substituted with CS3, there was no detectable processing at 
CS1 substituted with CS3.  These results demonstrate that P4-P1 CS amino acid 
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sequences are important determinants of PLP specificity in recognition and processing 
during virus replication, but also indicate that other determinants are involved in the 
regulation of PLP-mediated processing and maturation of intermediate and mature nsps 
1-3. 
 
Generation and recovery of CS replacement viruses 
 While the C-terminal half of nsp1 and all of nsp2 are dispensable for replication, 
alterations of CS/PLP interactions can be highly detrimental for MHV replication or 
protein processing (Graham and Denison, 2006; Kanjanahaluethai and Baker, 2000).  To 
determine the effect of alteration of the P4-P1 residues of CS1 and CS2, mutations were 
introduced into the MHV genome that resulted in substitutions of CS1 and/or CS2 with 
the P4-LKGG-P1 amino acid sequence of CS3, resulting in mutants CS1(3), CS2(3) and 
the dual cleavage-site mutant CS1/2(3) (Table 3.1).  These mutations also were 
introduced into a catalytically inactive PLP1 (P1ko) background (Graham and Denison, 
2006)(Fig. 3.2).  Cells were electroporated with genomic RNA for CS1(3), CS2(3), 
CS1/2(3), and CS1/2(3)+P1ko.  The single CS replacement mutant viruses, CS1(3) and 
CS2(3), exhibited cytopathic effect (CPE) by 24 h post-electroporation, and 90 to 100% 
of cells were involved in syncytia by 44 h post-electroporation, similar to WT virus.  For 
the double CS replacement viruses, CS1/2(3) and CS1/2(3)+P1ko, CPE was observed by 
36 h post-electroporation, and all cells were involved in syncytia by 54 h post-
electroporation, exhibiting a delay in CPE compared to WT virus.  When passage 1 (P1) 
virus stocks were sequenced across the cleavage sites and PLP1, all viruses retained the 
engineered mutations and no other mutations were identified within 300 nucleotides 
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flanking each side of the cleavage site.  The CS1/2(3)+P1ko mutant virus also retained 
the introduced C1121A/T1122A substitutions that inactivate PLP1 catalytic activity 
(Graham and Denison, 2006).  The results demonstrated that substitutions of the P4-P1 
residues at CS1 and CS2 allow recovery of viable viruses and are not required for 
replication. 
All of the above mutants were recovered on initial attempts using the reverse 
genetics approach for recovery.  The engineered substitution of the individual CS1(3) and 
CS2(3) substitutions in the P1ko background (CS1(3)+P1ko and CS2(3)+P1ko) were also 
tested for recovery. In dramatic contrast to all other mutants, the CS1(3)+P1ko and 
CS2(3)+P1ko mutants could not be recovered following multiple attempts by separate 
investigators in the lab.  In addition, no virus could be recovered even after  >1 week of 
blind passage of electroporated cells, a strategy that was successful for the previously 
reported highly debilitated P1ko mutant (Graham and Denison, 2006). The results 
indicate that in the setting of P1ko, substitution of both CS1(3) and CS2(3) is necessary 
for effective virus recovery and productive infection. In combination with the recovered 
viable mutants, the results suggest that there is cooperative activity between CS1, CS2, 
and PLP1, or that retention of an intact CS1 or CS2 results in altered interactions with 
inactivated PLP1 that hinder PLP2 activity or other functions of nsp1, 2, or 3.  
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Fig. 3.2.  Engineering of cleavage site substitution viruses.  The CS substitution viruses 
were engineered to replace the original CS amino acid sequences at CS1 and/or CS2 with that 
of the CS3 amino acid sequence P4-LKGG-P1.  Both CS substitutions were also engineered 
into a PLP1ko  (P1ko) background.  PLPs are shown as numbers in white (PLP1) or black 
(PLP2) boxes in nsp3.  Engineered catalytically inactivated PLP1 is shown as a gray hatched 
box.  Arrowheads indicate cleavage events of WT virus and are linked by white (PLP1) or 
black (PLP2).  P4 through P1 amino acid residues for each CS are shown below each diagram. 
White and black vertical bars show respective predicted PLP1 and PLP2 cleavage sites.  
Engineered substitutions are indicated by underlined amino acid sequences.  * indicates 
engineered mutant genomes that could not be recovered as infectious virus (see results). All 
other mutants were recovered in cell culture. 
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Single CS replacement viruses have altered protein processing 
 To determine the effects of substituting the CS3 LKGG amino acid sequence, the 
predicted MHV PLP2 recognition sequence, at CS1 or CS2 on protein processing, DBT 
cells were either mock-infected or infected with WT or the single CS substitution viruses, 
and cells were then labeled with [35S]Met-Cys.  Cytoplasmic lysates of infected cells 
were immunoprecipitated with antibodies against nsp1 (28 kDa), nsp2 (65 kDa), nsp3 
(210 kDa), and the 3CLpro-processed nsp8 (22 kDa).  For WT virus, all nsps tested were 
detected in their mature form, as well as an nsp2-3 precursor that has been previously 
described (Fig. 3.3A and 3.3B)(Graham and Denison, 2006; Graham et al., 2006).  The 
ΔCS1 virus (Denison et al., 2004), where the two amino acids upstream and one amino 
acid downstream of CS1 were deleted, was used as a control for comparison of the 
processing phenotype of the CS1(3) mutant virus.  The ΔCS1 and the CS1(3) mutant 
virus exhibited identical protein processing phenotypes, and each virus produced mature 
nsp3 and nsp8, confirming that catalytic activity of all three proteases was intact.  Unlike 
WT virus, both the ΔCS1 and CS1(3) mutant viruses exhibited nsp1-2 and nsp1-2-3 
fusion proteins and lacked detection of mature nsp1, suggesting that the LKGG amino 
acid sequence substituted at CS1 is not processed by either PLP1 or PLP2.   
 Similar to WT virus, all nsps that were tested by immunoprecipitation were 
detected in their mature form for the CS2(3) mutant virus.  Also, an nsp2-3 intermediate 
protein was detected in the CS2(3) virus, which is seen in WT, and there was no detection 
of any other precursor or intermediate proteins.  Unlike the ΔCS2 mutant virus (Graham 
and Denison, 2006), where the P2 through P1’ residues of the CS amino acid sequence 
were deleted and which exhibits no detection of mature nsp2 or nsp3, the CS2(3) virus is  
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Fig. 3.3.  Protein processing of single CS substitution viruses. A) Schematics show patterns of 
WT and mutant virus protein processing from results in panel B.  Mutations that were introduced 
into mutant viruses, cleavage sites, P4-P1 residues and PLPs are as in Fig. 3.2.  X’s and vertical 
dashed lines indicate CS deletions where the P2 through P1’ amino acids were deleted. A dashed 
white arrowhead indicates reduced cleavage and protease not determined. ⊥ indicates no 
cleavage.  A dashed ⊥ indicates possible but non-detected cleavage.  B) Lysates from 
radiolabeled infected DBT cells were immunoprecipitated with α-nsp1, α-nsp2, α-nsp3, or α-
nsp8 as indicated and resolved by 4 to 12% SDS-PAGE and imaged by fluorography.  Mature 
(nsp1, 2, 3, 8), intermediate (nsp2-3), and non-cleaved proteins (nsp1-2-3, and nsp1-2) are 
indicated at the right of the gels, with molecular mass markers at the left.  L, ladder.  Mock, 
mock-infected cells. All images were obtained from a single experiment with separate gels for 
nsp 1, 2, 3 and 8 immunoprecipitations, and were equivalently treated and exposed to film. 
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capable of processing nsp2 and nsp3 into their mature forms.  However, mature nsp2 and 
nsp3 in the CS2(3) mutant were present at reduced levels compared to WT virus.  
Interestingly, the nsp2-3 intermediate protein was detected at higher levels in the CS2(3) 
mutant virus than that of WT virus.  For the CS2(3) virus, the abundance of the nsp2-3 
precursor correlated with reduced levels of mature nsp2 and nsp3, while the abundance of 
mature nsp2 and nsp3 correlated with a reduction in the nsp2-3 precursor seen in WT 
virus.  These data indicate that processing occurs at the LKGG amino acid sequence at 
CS2, albeit at reduced efficiency compared to WT virus.  These data do not indicate, 
however, which PLP processes at the mutated cleavage site.  The results also suggest that 
there is significant flexibility at CS2 in PLP recognition and processing of the cleavage 
site, while there is less flexibility in recognition and processing at CS1. 
 
CS1(3) and CS2(3) mutant viruses exhibit varied  
phenotypes in single-cycle growth experiments 
 Viral growth experiments were performed to determine if defects in protein 
processing exhibited by the CS1(3) and CS2(3) mutant viruses were associated with 
impairments in virus replication (Fig. 3.4).  DBT cells were infected at multiplicities of 
infection (MOIs) of 1 and 0.05 PFU/cell, supernatant was harvested at various times from 
1 to 30 h p.i., and virus titers were determined by plaque assay.  In single-cycle growth 
experiments, the CS1(3) mutant virus exhibited exponential growth similar to WT and 
ΔCS1 mutant viruses (Fig. 3.4A).  The CS1(3) mutant virus also displayed a decrease in 
growth from 4 to 10 h p.i. compared to WT virus.  Unlike the ΔCS1 virus which reaches 
peak titers approximately 10-fold less than WT virus, the CS1(3) virus reaches peak titers 
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similar to WT virus at 12 h p.i.  To determine the extent of the growth defects exhibited 
between 4 and 10 h p.i. in the CS1(3) mutant virus, I next tested if the CS1(3) virus 
exhibited more profound growth defects at a lower MOI (Fig. 3.4B).  In contrast to the 
single-cycle growth experiment, the CS1(3) virus did not reach WT titers, exhibiting a 
0.5 log10 reduction.  The CS1(3) virus also displayed an approximate 0.5 log10  increase in 
peak titers compared to the ΔCS1 mutant virus.  Lastly, WT, ΔCS1, and CS1(3) viruses 
all displayed similar growth kinetics at a low MOI.  These results also indicate that 
deletion of CS1 has an increased impairment on growth than that of substitution of the 
native G-Y-R-G amino acid sequence for the CS3 LKGG amino acid sequence. 
 Similar to the CS1(3) mutant virus, the CS2(3) mutant virus grew similar to WT 
and reached peak titers at 12 h p.i., but the CS2(3) mutant virus also exhibited a slight 
decrease in growth at 8 h p.i. compared to WT virus (Fig. 3.4C).  The ΔCS2 mutant virus 
was used as a control and exhibited an approximate 4 h delay in the exponential phase of 
growth but still reached WT titers.  To examine whether the CS2(3) virus displays 
replication defects that are not observed in single-cycle growth experiments, growth 
assays were performed at a low MOI (Fig. 3.4D).  Unlike the CS1(3) mutant virus which 
had greater replication defects at a lower MOI, the CS2(3) virus grew indistinguishable 
from WT virus.  These findings indicate that replacement of the CS2 F-P-C-A amino acid 
sequence by the CS3 LKGG amino acid sequence has no effect on overall virus growth, 
even though there is reduced processing at the mutated CS (Fig. 3.3B). 
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Fig. 3.4.  Growth analysis of single CS substitution viruses.  DBT cells were infected with the 
indicated viruses for either single cycle growth (MOI of 1 PFU/cell) or multiple cycle growth  
(MOI of 0.05 PFU/cell) experiments, and titers were determined by plaque assay.  Samples of virus 
supernatants were collected at predetermined time points between 1 and 30 h p.i.  (A) Single cycle 
growth of the CS1(3) mutant virus.  (B) Multiple cycle growth of the CS1(3) virus.  (C) Single 
cycle growth of the CS2(3) mutant virus.  (D) Multiple cycle growth of the CS2(3) virus. The 
ΔCS1 and ΔCS2 viruses were used as controls in the growth experiments.  Data points indicate the 
hours when media was harvested for determining titer. Error bars represent standard deviation 
between samples. 
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MHV PLP2 processes at CS2 with an LKGG amino acid motif 
 Because CS1(3) and CS2(3) mutant viruses were viable and to determine if PLP2 
can process at altered CS1 and CS2 with LKGG amino acid substitutions, mutant viruses 
were engineered to  contain the LKGG amino acid sequence at both CS1 and CS2 in the 
presence or absence of a catalytically active PLP1(Fig. 3.5A).  To examine the protein 
processing phenotypes of CS1/2(3) and CS1/2(3)+P1ko viruses, protein 
immunoprecipitations were performed on radiolabeled, infected cell lysates, and samples 
were subjected to SDS-PAGE and exposed to film (Fig. 3.5B and 3.5C).  Mutant viruses 
that had deletions of CS1 and CS2 (ΔCS1/2) and both the deletions of CS1 and CS2 in 
the presence of a catalytically inactivated PLP1 (ΔCS1/2+P1ko) were used as 
controls(Graham and Denison, 2006).  In contrast to WT, nsp1, 2, and 3 proteins and 
precursors were much less abundantly detected, even after prolonged labeling for all 
mutant viruses tested. Since nsp8 was detected, the preceding proteins were translated in 
at least equivalent amounts, thus, their lesser detection could result from aberrant folding, 
lack of availability of antibody epitopes, or possibly due to degradation. Nevertheless, it 
was still possible to discern different patterns of processing.  Both the ΔCS1/2 and 
ΔCS1/2+P1ko mutant viruses exhibited identical protein processing phenotypes, 
displaying an nsp1-2-3 fusion protein and mature nsp8, which was used to show that 
3CLpro processing activity remained intact. The CS1/2(3) and CS1/2(3)+P1ko mutant 
viruses exhibited identical protein processing patterns when compared to one another.  
Similar to the CS deletion viruses, both the double CS replacement viruses displayed 
detection of mature nsp8 and an nsp1-2-3 precursor protein.  Like WT virus, mature nsp3 
was detected in the double CS replacement viruses, confirming that PLP2 catalytic  
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Fig. 3.5.  Protein processing of double CS substitution viruses. A) Schematics are shown of 
WT and mutant viruses that were used in the protein processing experiments shown in the gels 
below. Notation for schematics is as in Figures 2 and 3. B) and C) DBT cells were either 
mock-infected or infected with the viruses indicated above the gels.  Cells were grown in the 
absence of Met and Cys for 1 h starting at 5 h p.i., and proteins were radiolabeled for WT 
infection until 80% of cells exhibited CPE or for a total of 8 h.  Cell lysates were 
immunoprecipitated with α-nsp1, α-nsp2, α-nsp3, or α-nsp8.  The indicated mature, 
intermediate, and fusion proteins are indicated at the right of the gels.  Molecular weights in 
kDa are shown at the left. All images in B were obtained from multiple gels from a single 
experiment with identical exposures. No modifications to the gels were performed. C) Lanes 
from top panel in B were individually adjusted for brightness and contrast for exposure of nsp3 
to show relationships of nsp1-2-3, nsp2-3, and nsp3.    
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activity was intact.  Unlike that of WT virus, no mature nsp1, nsp2, or nsp2-3 
intermediate proteins were detected in the CS replacement viruses.  Unlike that of WT 
and double CS deletion viruses, the double CS replacement viruses also displayed 
detection of an nsp1-2 fusion protein.  Because the CS1/2(3)+P1ko mutant virus 
exhibited an nsp1-2 fusion protein and mature nsp3, protein processing occurs at the 
substituted CS3 amino acid sequence LKGG at the second CS position.  Due to 
inactivation of the PLP1 catalytic activity in the CS1/2(3)+P1ko virus, PLP2 is capable of 
processing the substituted CS3 amino acid sequence at the CS2 position.  However, there 
was no detection of mature nsp1 in the CS1/2(3)+P1ko virus, suggesting that PLP2 does 
not cleave at CS1 substituted with an LKGG amino acid motif. 
 
Double CS replacement viruses exhibit both delays and decreases in virus growth 
 Since the double CS replacement viruses were viable and exhibited altered 
processing phenotypes compared to WT and the double CS deletion viruses, I analyzed 
the effects of altered processing on the growth of the double CS replacement viruses at an 
MOI of 1 PFU/cell (Fig. 3.6A).  The CS1/2(3) and CS1/2(3)+P1ko mutant viruses 
displayed identical growth, exhibiting a 4 h lag in exponential growth and a slight 
decrease in peak titers compared to WT virus.  Growth analysis was not performed at a 
high MOI with the control ΔCS1/2 and ΔCS1/2+P1ko viruses due to the low titers of both 
stocks; therefore, an MOI of 0.05 was used to analyze and compare growth between the 
double CS replacement viruses and the double CS deletion viruses in multiple rounds of 
infection (Fig. 3.6B).  Similar to an MOI of 1 PFU/cell, the double CS replacement 
viruses grew indistinguishable from each other and exhibited a 4 h lag and a 0.5 log10  
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Fig. 3.6.  Growth analysis of double CS substitution viruses.  DBT cells were either infected 
with WT or double CS substitution viruses for growth analysis.  Samples of virus supernatants 
were collected at predetermined time points between 1 and 30 h p.i. (A) Single cycle growth (MOI 
of 1 PFU/cell).  (B) Multiple cycle growth (MOI of 0.05 PFU/cell).  The double CS deletion 
viruses were used as controls in the growth expereiment shown in panel B.  Data points represent 
the titer from media harvested at the indicated time points.  The double CS substitution viruses and 
their CS deletion counterparts are linked in boxes and triangles with identical dashed lines for 
clarity.  Error bars represent standard deviation of the mean between samples. 
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reduction in peak titer compared to WT virus.  The double CS replacement viruses 
exhibited the same delay in exponential growth as the double CS deletion viruses; 
however, peak titers were approximately 1 log10 higher in the CS replacement viruses.  
Also, introduction of catalytically inactive PLP1 had no affect on growth of the double 
CS replacement virus.  This growth analysis demonstrates that replacing both CS1 and 
CS2 with an LKGG amino acid motif results in more robust growth than that of the 
double CS deletion viruses, but the double CS replacement viruses have reduced growth 
fitness compared to either replacing CS1 or CS2 amino acid sequences alone (Fig. 3.4). 
 
Discussion 
 To determine if requirements other than CSs and PLPs are necessary for protein 
processing of nsps 1-3 of MHV, we tested whether replacement of proximal CS amino 
acid residues was sufficient to switch PLP specificity and if the CS substitutions affected 
virus growth and the regulation and processing of intermediate and mature proteins of 
MHV.  In this report, we have demonstrated that MHV PLP2 is capable of processing 
directly downstream of its recognition sequence, P4-LKGG-P1, at a different location in 
the replicase polyprotein.  Specifically, substitution of the LKGG amino acid sequence 
for FPCA at CS2 allows processing by PLP2, albeit at reduced efficiency compared to 
processing at the natural location in WT virus.  Although processing occurred at the 
LKGG amino acid sequence at CS2, there was no detection of processing at CS1 that was 
substituted with the LKGG motif.  Therefore, it is possible to switch protease specificity 
with the proximal CS recognition sequence; however, other determinants, besides the 
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proximal CS amino acid sequence, are required for PLP recognition and/or efficient 
processing. 
 The altered processing phenotypes of the CS substitutions resulted in differential 
effects on virus growth. The CS1(3) virus, where CS3 was substituted at the CS1 position 
in the genome, exhibited no detectable signs of processing at the mutated cleavage site, 
yet virus growth is more robust than that of the ΔCS1 mutant virus.  This suggests two 
possibilities for the increased growth fitness.  First, the substituted LKGG sequence at 
CS1 alters the nsp1-2 fusion protein and allows for more intact functions of the fused 
nsp1-2 protein than deletion of CS1. Alternatively, protein processing at the substituted 
LKGG amino acid motif at CS1 may be occurring at levels below the limit of detection 
but sufficient to enhance replication fitness.  Also, the CS1(3) virus and the double CS 
replacement viruses have similar processing patterns, reach similar peak titers, yet the 
double CS replacements exhibit a delay in exponential growth, suggesting CS1 and CS2 
may function cooperatively or as a unit and defects in processing at both CS1 and CS2 
result in the additive detrimental effects on processing and virus replication. 
 A previously published report from our lab has shown that the catalytic 
inactivation of PLP1 alone results in recovery of a virus that exhibits severely debilitated 
growth, reaching peak titers 5 to 6 log10 PFU/ml less than WT virus (Graham and 
Denison, 2006). In the present study, the introduction of a catalytically inactive PLP1 into 
the background of either the double CS replacement or the double CS deletion viruses has 
no effect on processing or growth when compared to the double CS replacement or 
double CS deletion viruses with intact PLP1 activity.  This data suggests that either 
deletion or CS substitution of CS1 and CS2 blocks the recognition and binding of PLP1 
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with the altered CS.  This data also suggests that the ablation of the catalytic activity of 
PLP1 does not influence recognition and binding of the PLP with its respective CSs.  
Therefore, we speculate that the inactivated PLP could still bind the native CSs but not 
cleave the recognized amino acid sequences, resulting in prolonged or irreversible 
binding of the inactive PLP1 with the native CSs, thus impairing nsps 1-3 functions.  This 
possibility is supported by the comparison of the severely debilitated growth seen in the 
P1ko and increased growth observed in the ΔCS1/2+P1ko and CS1/2(3)+P1ko viruses 
(Graham and Denison, 2006). This model also could explain our inability to recover the 
CS1(3) + PL1ko and  CS2(3) + PL1ko mutant viruses, where one intact PLP1 CS may 
interact with inactive PLP1 to alter nsp1-2-3 folding, processing, and function.  Future 
studies will test this model by deletion of the PLP1 domain of nsp3 or the PLP1 substrate 
binding and catalytic residues in the setting of combinations of intact, deleted, and 
substituted, CS1, CS2, and CS3. 
 PLP-mediated processing at substituted cleavage sites.  The observed defects 
in protein processing exhibited by the CS substitution viruses may be due to several 
potential factors.  One potential model is that MHV PLP2 requires more than the 
proximal LXGG amino acid motif for efficient recognition and/or processing at CSs. In 
vitro analysis of SARS-CoV PLpro demonstrated that an LXGG amino acid sequence 
was both necessary and sufficient for PLpro processing (Barretto et al., 2005).  MHV 
PLP2 and SARS-CoV PLpro share 32% identity and 44% amino acid sequence 
similarity, and structural modeling of MHV PLP2 based on SARS-CoV PLpro crystal 
structure predicted similar structures and substrate binding pockets (Sulea et al., 2006).  
However, in vitro analysis of MHV CS3 demonstrated that a P6 Phe-to-Ala substitution 
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inhibited PLP2 processing at CS3 (Kanjanahaluethai, Jukneliene, and Baker, 2003).  
Since only Ala substitution was tested at the P6 position, it remains unknown if P6 Phe is 
absolutely required for WT-like processing by PLP2 at CS3. Our engineered CS1(3) has 
a P6-Trp, while CS2(3) has a P6-Leu. We can conclude that P6-Leu allows processing by 
PLP2 following LKGG.  Our system will allow us to determine whether differences in P6 
or other residues affect PLP2 recognition and cleavage at CS1 and CS2, for example by 
substituting Trp, Leu or Phe at each location. Additionally, it may be possible to use 
adaptive passage of the debilitated CS1/2(3) mutants with and without P1ko to 
recapitulate the evolution of an optimal protease/cleavage site interaction. 
 Coronaviruses:  one or two PLPs?  While at least one PLP domain is absolutely 
conserved among coronaviruses, two PLP domains are only conserved in the group 1 and 
group 2a coronaviruses.  In these coronavirus groups, CS amino acid sequences are more 
divergent and potentially need two PLPs to efficiently process nsps 1-3.  This led to the 
hypothesis that proximal CS amino acid sequences were the major determinant for PLP 
recognition and processing.  Our results, however, show that CS amino acid sequences 
are not the only determinants for PLP recognition and processing and encoding one or 
two active PLPs within nsp3.  The requirement of one or two active PLPs may be due to 
other functions of the PLP enzymes.  In addition to processing nsps 1-3, coronavirus 
PLPs have been shown to be multifunctional enzymes.  Both SARS-CoV PLpro and 
MHV PLP2 are potent inhibitors of type I interferon production (Lindner et al., 2005; 
Zheng et al., 2008), suggesting that these enzymes may also promote viral growth in 
infected hosts.  Also, both of these enzymes, as well as PLP2 from HCoV-NL63, have 
shown to be deubiquitinating enzymes (Barretto et al., 2005; Chen et al., 2007; Lindner et 
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al., 2005; Zheng et al., 2008).  This function of SARS-CoV PLpro, HCoV-NL63 PLP2, 
and MHV PLP2 suggests that coronaviruses employ a strategy to hijack or modulate the 
host cell ubiquitination machinery to help support virus replication.  While functions of 
SARS-CoV PLpro, HCoV-NL63 PLP2, and MHV PLP2 domains have been studied, 
little is known about possible functions of PLP1 domains, besides their roles in 
polyprotein processing.  Therefore, group 1 and 2a coronaviruses may encode PLP1 
enzymes that have multiple functions, which are beneficial to virus replication in their 
particular host. The use of one or two PLPs is consistent within phylogenetic coronavirus 
groups, even within more closely related, recently defined subgroups such as 2a (MHV) 
and 2b (SARS-CoV).  It is reasonable to speculate that paralogous duplication or loss of a 
second PLP and correlated alteration of cleavage site specificity could represent an 
important evolutionary event in the divergence and adaptation of coronaviruses (Ziebuhr, 
Thiel, and Gorbalenya, 2001).  
 To date, this is the first report to test the effects of switching RNA virus 
polyprotein CS recognition sequences, which resulted in processing by a different viral 
protease, on replication and protein processing.  While the engineered MHV viruses 
resemble the relationship of CSs and protease activities of SARS-CoV nsps 1-3, the 
engineered mutations were detrimental for MHV replication. Both the findings that 
protease specificity can be altered and that the alteration of cleavage site/protease 
interactions are detrimental to virus replication suggest that the MHV mutants may be 
powerful tools to study the implications of rewiring coronavirus nsps 1-3 and altering 
protease specificity on virus replication, pathogenesis, and attenuation.  These potential 
future directions will be discussed in detail in Chapter V. 
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CHAPTER IV 
 
MURINE HEPATITIS VIRUS NSP4 REGULATES VIRUS-INDUCED MEMBRANE 
MODIFICATIONS AND REPLICATION COMPLEX FUNCTION 
 
Introduction 
Coronavirus nsps 1-4 are intricately linked by PLP-mediated processing, and 
these processing events are important for regulating the functions of intermediate and 
mature proteins during the virus life cycle, including the timing and formation of 
replication complexes.   
All positive-strand RNA viruses rely on host intracellular membranes to form 
replication complexes, which are defined as the sites of viral RNA synthesis (Denison, 
2008; Novoa et al., 2005; Restrepo-Hartwig and Ahlquist, 1996; Salonen, Ahola, and 
Kaariainen, 2005; Schaad, Jensen, and Carrington, 1997).  These virus-induced 
membrane modifications are critical for creating an environment that supports viral RNA 
synthesis, as well as protecting newly-synthesized viral RNA.  For many positive-strand 
RNA viruses, specific replicase proteins, often containing multiple hydrophobic domains, 
have been implicated in targeting to and modifying host membranes, ultimately leading 
to the formation of replication complexes.  Analysis of amino acid sequences and in vitro 
biochemical studies of coronavirus nsps 3, 4, and 6 have shown that these three nsps all 
have transmembrane domains that are likely important for virus-induced membrane 
modifications (Baliji et al., 2009; Kanjanahaluethai et al., 2007; Lee et al., 1991).  In this 
chapter, the role of MHV nsp4 was determined for several processes in the coronavirus 
life cycle through the utilization of multiple experimental approaches.  
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MHV nsp4 is processed by papain-like protease 2 (PLP2) at its amino terminus, 
resulting in an nsp4-10 precursor, and after this initial processing event, nsp5 (3Clpro) 
mediates processing at the carboxy terminus of nsp4 (Fig. 4.1A) (Gosert et al., 2002; 
Harcourt et al., 2004; Kanjanahaluethai and Baker, 2000; Kanjanahaluethai and Baker, 
2001; Kanjanahaluethai, Jukneliene, and Baker, 2003).  The predicted molecular mass of 
nsp4 is 56-kDa, but it is detected as a 44-kDa protein by SDS-PAGE (Kanjanahaluethai 
and Baker, 2001; Lu, Lu, and Denison, 1996).  
All tested coronavirus nsps localize to replication complexes that are located on 
virus-induced double membrane vesicles (DMVs), and nsp4 has been proposed to play 
roles in the formation, organization, and function of these virus replication complexes 
(Gosert et al., 2002; Perlman and Netland, 2009).  Nsp4 has been shown to associate with 
membrane fractions of infected cells and is resistant to membrane extraction following 
Triton X-114 treatment, indicating that nsp4 is an integral membrane protein (Gosert et 
al., 2002).  Bioinformatics of MHV nsp4 amino acid sequence predicted that nsp4 has 
four transmembrane domains (TM1-4).  MHV nsp4 has also been shown to be required 
for rescue of infectious virus (Sparks, Lu, and Denison, 2007), as well as TM1-3, but 
TM4 is dispensable for recovery of infectious virus in cell culture.  Charge-to-alanine 
substitutions between TM1 and TM2 of nsp4 result in viruses with phenotypes ranging 
from non-recoverable to viruses that exhibit reduced virus growth, RNA synthesis, and 
protein processing (Sparks, Lu, and Denison, 2007).  
Analysis of nsp4 from multiple coronaviruses across all coronavirus groups 
predicts N-linked glycosylation sites for all tested nsp4 sequences.  The glycosylation 
sites, or sequons, Asn-X-Ser, Asn-X-Thr, and rarely Asn-X-Cys are amino acid 
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sequences that are recognized for glycosylation of the Asn (N) residue.  Even though 
coronaviruses contain putative glycosylation sites within nsp4, there is little conservation 
of these sites between groups.  Group 2a coronaviruses, such as MHV and human 
coronavirus HCoV-OC43, have two conserved putative N-linked glycosylation sites, 
N176 and N237 (Fig. 4.1B), while the group 2b SARS-CoV and group 3 Avian 
Infectious Bronchitis Virus (IBV), have different putative glycosylation sites, N131 or 
N48, respectively (Lim, Ng, and Liu, 2000; Oostra et al., 2007).  Although the 
glycosylation of nsp4 from group 1 coronaviruses has not been investigated, residues 
N176 and N237 of MHV nsp4, N131 of SARS-CoV, and N48 of IBV nsp4 have been 
shown to be glycosylated when nsp4 is plasmid-expressed in cells or when nsp4 is 
expressed from non-native locations in the coronavirus genome (Clementz et al., 2008; 
Lim, Ng, and Liu, 2000; Oostra et al., 2007).  Clementz et al. reported that N176 of MHV 
nsp4 is not required for virus replication, and that an N176A mutant virus grows 
identically to wild-type (wt) virus (Clementz et al., 2008).  In that study, the N176A 
mutant virus-expressed nsp4 migrated faster than wt nsp4 by SDS-PAGE, consistent with 
altered protein modification such as loss of glycosylation. However, this was not further 
investigated in the study. In contrast, N237A and N176A/N237A mutant viruses could 
not be recovered. 
Although these studies have led to an increased understanding of various aspects 
of nsp4, it remains unknown if N176 and/or N237 are glycosylated during infection and 
if the putative nsp4 glycosylation sites of MHV or other coronaviruses serve roles in 
membrane modifications or replication complex formation and function. In this study, I 
tested the glycosylation status of MHV nsp4, expressed from its native genomic location, 
 74 
and the role of nsp4 glycosylation sites on virus growth, viral RNA synthesis, nsp4 
localization, and replication complex morphology by engineering and recovering nsp4 
mutants with alanine substitutions at N176 (N176A), N237 (N237A), or both 
(N176A/N237A).  Results show that virus-expressed nsp4 is glycosylated at both N176 
and N237 during infection, that glycosylation at either or both sites is dispensable for 
virus growth in cell culture, and that alanine substitution of N176, N237, or both results 
in defects in virus growth and RNA synthesis.  Further, results demonstrate that loss of 
nsp4 glycosylation is associated with the presence of aberrant or disrupted double 
membrane vesicles (hereafter referred to as irregular DMVs) and increased prevalence of 
virus-induced convoluted membranes (CMs).  The degree of irregular DMVs and 
increased CMs from the nsp4 mutant viruses directly correlated with an impairment in 
viral RNA synthesis and growth. These results demonstrate that nsp4 plays a critical role 
in the formation, stability, and structure of virus-induced membrane modifications.  
Finally, the results also support the conclusion that the physical structure and stability of 
DMVs is essential for efficient RNA synthesis and/or protection of viral RNAs and 
optimal replication of coronaviruses.  
 
Generation and recovery of nsp4 glycosylation mutant viruses 
 Group 2a coronaviruses contain conservation of putative glycosylation sites in 
nsp4 at N176 and N237 (Fig. 4.1B). To determine if nsp4 is glycosylated at residues 
N176 and N237 in the context of MHV infection and what roles nsp4 glycosylation may 
play in the virus life cycle, viruses were engineered to contain asparagine-to-alanine 
substitutions at either N176, N237, or both residues N176 and N237 of nsp4 (Fig. 4.1C 
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and Table 4.1).  Cells were electroporated with genomic RNA for N176A, N237A, or 
N176A/N237A mutant viruses.  All three mutant viruses induced cytopathic effect (CPE) 
by 36 h post-electroporation, and 90 to 100% of cells were involved in syncytia by 46 to 
50 h post- electroporation, similar to wt virus.  Viruses were passaged and sequenced 
across the nsp4 coding sequence, confirming both the presence of engineered mutations 
and lack of any other mutations in nsp4.  In contrast to previous reports, these results 
demonstrate that mutants with alanine substitution at N176, N237, or both are viable, 
demonstrating that the N176 and N237 residues are not required for replication in cell 
culture.  To determine if compensating mutations occurred outside of the nsp4 sequence 
during recovery of N237A and N176A/N237A mutant viruses, the complete genome of 
the N176A/N237A mutant virus was sequenced, and there were no additional mutations 
present in the genome.  These results demonstrate that the recovery of N237A and 
N176A/N237A mutant viruses was not due to second site compensating mutations and 
that the Asn residues are not required for virus viability.  
 
Nsp4 is glycosylated at both N176 and N237 during MHV infection 
Previous studies have demonstrated that treatment of lysates with 
endoglycosidase H (Endo H) results in a mobility shift of nsp4 expressed from plasmid in 
HeLa cells (Clementz et al., 2008; Oostra et al., 2007) or from nsp4-EGFP expressed in 
recombinant virus from an alternate location (in place of ORF2) (Clementz et al., 2008; 
Oostra et al., 2007), consistent with glysosylation of nsp4 with mannose-rich 
oligosaccharides in the ER and lack of nsp4 trafficking through Golgi. However, there 
has been no demonstration of N-linked glycosylation of native nsp4 in wt virus or
 76 
 
T
ab
le
 4
.1
. 
 A
sp
ar
ag
in
e-
to
-a
la
n
in
e 
m
ut
ag
en
es
is
 o
f 
M
H
V
 n
sp
4
 
P
ri
m
er
 N
a
m
e
 
S
eq
u
en
c
e
 
P
u
r
p
o
se
 
N
1
7
6
A
 S
en
se
 
5
'-
G
C
C
 G
C
C
 T
C
T
 C
T
G
 T
A
T
 A
G
T
 T
C
T
 T
T
G
 G
C
T
-3
' 
M
u
ta
g
en
es
is
 f
o
r 
N
1
7
6
A
 
N
1
7
6
A
  
A
n
ti
se
n
se
 
5
'P
-G
T
G
 C
A
T
 A
A
C
 A
C
C
 C
C
C
 T
G
T
 A
T
A
  
A
C
A
  
A
T
A
  
A
G
G
-3
' 
M
u
ta
g
en
es
is
 f
o
r 
N
1
7
6
A
 
N
2
3
7
A
 S
en
se
 
5
'-
G
C
C
 C
G
T
 T
C
A
 T
G
G
 G
T
A
 T
T
G
 A
A
C
 A
A
C
 C
C
G
 T
A
T
-3
' 
M
u
ta
g
en
es
is
 f
o
r 
N
2
3
7
A
 
N
2
3
7
A
  
A
n
ti
se
n
se
 
5
'P
-A
A
A
  
A
T
T
 A
A
A
 G
C
A
 G
A
T
 A
C
C
 C
T
C
 C
T
C
 G
G
C
-3
' 
M
u
ta
g
en
es
is
 f
o
r 
N
2
3
7
A
 
*
U
n
d
er
li
n
ed
 l
et
te
rs
 d
en
o
te
 n
u
cl
eo
ti
d
es
 u
se
d
 t
o
 i
n
tr
o
d
u
ce
 a
la
n
in
e 
su
b
st
it
u
ti
o
n
s 
 
 77 
 
 
Fig. 4.1.  Processing, glycosylation, and mutagenesis of nsp4.  A)  Schematic of MHV nsp4 
processing.  Three virus-encoded proteases process polyprotein 1ab (pp1ab) into intermediate 
precursors and 16 mature nsps.  Papain-like proteases 1 and 2 (PLP1 and PLP2) are shown as 
black boxes within nsp3, while the nsp5 protease (3CLpro) is shown in gray.  PLP-mediated 
processing of nsps is linked by white boxes, and 3CLpro processing is linked by gray boxes.  
Nsp4 is shown in black.  Nsps are indicated by number.  The nsp4-10 precursor is also shown.  
B) Proposed topology and N-linked glycosylation sites of nsp4.  MHV nsp4 is a 496-aa 
protein that has four predicted transmembrane domains (TM 1-4, black rectangles) and five 
soluble regions (SR a-e).  Location of N-linked glycosylation residues Asn176 and Asn237 
(N176 and N237) are indicated in SRb and predicted luminal and cytoplasmic domains are 
indicated (Oostra et al., 2007).  C) Engineered nsp4 glycosylation mutants.  Nsp4 
glycosylation mutants were engineered by replacing the AAT asparagine codons at both N176 
and N237 with a GCC alanine codon.  Nucleotide numbers correspond to genomic position, and 
amino acid numbers correspond to nsp4 position. 
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identification of specific Asn residues subject to N-linked glycosylation.  To test whether 
natively expressed MHV nsp4 is glycosylated during infection, immunoprecipitated nsp4 
from wt MHV infection was mock-treated or treated with Endo H (Fig. 4.2A). Mock-
treated nsp4 was detected as a 44 kDa protein by SDS-PAGE, while Endo H treatment 
resulted in a faster migrating, 39 kDa protein. The nsp4-10 precursor was detected in both 
cases by α−nsp4.  The replicase protein nsp8 is not modified by N-linked glycosylation 
and was not affected by Endo H treatment (Fig. 4.2A).  The nsp4-10 precursor that was 
treated with Endo H and detected using anti-nsp8 exhibited a sharper band than that of 
the untreated nsp4-10 precursor.  A possible explanation for this is that removal of N-
linked glycans may alter what nsp4-10 precursors can be detected by anti-nsp8, e.g. nsp4-
10 with certain posttranslational modifications. 
To test whether N176 and/or N237 were targeted for glycosylation, nsp4 
immunoprecipitated following infection of DBT cells with N176A, N237A, and 
N176A/N237A mutant viruses was treated with Endo H (Fig. 4.2B).  Untreated nsp4 
from N176A and N237A mutants migrated identically and more rapidly than untreated wt 
nsp4 (42 kDa), but more slowly than wt nsp4 treated with Endo H (39 kDa).  When nsp4 
from N176A and N237A mutant viruses was treated with Endo H, both proteins were 
detected at 39 kDa, identical to Endo H-treated wt nsp4.  Nsp4 from the N176A/N237A 
mutant virus migrated to 39 kDa, whether untreated or treated with Endo H. The results 
indicate that nsp4 expressed from its native genomic location is specifically glycosylated 
at residues N176 and N237 and also demonstrate that no other N-linked glycosylation 
occurs in nsp4. 
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Fig. 4.2.  Protein expression and glycosylation of nsp4.  Cytoplasmic lysates 
were generated from radiolabeled DBT cells that were either mock-infected or 
infected with wt, N176A, N237A, or N176A/N237A viruses.  Labeled proteins 
were immunoprecipitated using antiserum against nsp4 or nsp8.  A) Endo H 
treatment of wt nsp4 and nsp8.  Immunoprecipitated nsp4 and nsp8 were either 
mock-treated or treated with Endo H to analyze N-linked glycosylation.  After 
Endo H treatment for 3 h, proteins were resolved on SDS-PAGE and visualized by 
fluorography.  Black dots indicate either glycosylated or unglycosylated forms of 
nsp4.  B) Endo H treatment of nsp4 glycosylation mutants.  Immunoprecipitated 
nsp4 from wt or nsp4 glycosylation mutants was mock-treated or treated with Endo 
H.  All samples in each individual panel were resolved on the same gel and had the 
same exposure time, but in panel B, the images were cropped to remove non-
relevant lanes.  Molecular weight markers are shown to the left of each gel. 
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Nsp4 glycosylation mutant viruses exhibit defects in virus replication 
To determine whether nsp4 glycosylation mutant viruses display replication defects, DBT 
cells were infected with wt, N176A, N237A, and N176A/N237A viruses at an MOI of 1 
PFU/cell (Fig. 4.3A).  Samples of infected cell culture medium were taken at 
predetermined time points from 1 to 24 hours post-infection (h p.i.), and virus titers of 
each sample were determined by plaque assay.  The N176A mutant virus exhibited 
growth kinetics and peak titers indistinguishable from wt virus, consistent with the study 
by Clementz et al (Clementz et al., 2008). The N237A and N176A/N237A mutant viruses 
grew indistinguishably from each other and reached peak titers similar to wt virus; 
however, compared to wt and N176A, the N237A and N176A/N237A viruses exhibited a 
delay and decrease in growth between 4 and 12 h p.i.  The N176A/N237A mutant did not 
appear more impaired in growth than the N237A mutant alone.  Since the N237A and 
N176A/N237A mutant viruses exhibited growth defects, experiments were performed 
that next tested whether N176A had subtle growth defects by repeating the growth assays 
at an MOI of 0.01 PFU/cell (Fig. 4.3B).  Under these conditions the N237A and 
N176A/N237A mutants demonstrated the same delay as with a higher MOI. In contrast, 
for the N176A mutant virus, the lower MOI infection revealed a subtle defect in growth, 
displaying a delay in peak titer similar to that of N237A and N176A/N237A mutants.  
The experiments demonstrate that N176 and N237 both are important for exponential 
growth, but loss of either or both glycosylation sites still allows for wt peak titers. The 
contributions of N176 and N237 are independent and non-redundant, as indicated by 
growth defects of either N176A or N237A, but are not additive or synergistic. Finally, the  
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Fig. 4.3.  Growth analysis of nsp4 glycosylation mutant viruses.  DBT cells 
were infected with the indicated viruses for: A) single cycle growth at an MOI of 
1 PFU/cell for 24 h; or B) for multiple cycle growth at an MOI of 0.01 PFU/cell 
for 30 h.  Samples of virus supernatants were collected at times indicated beneath 
the graphs.  Virus titers were determined by plaque assay with DBT cells.  Error 
bars represent standard deviations from the mean based on samples from multiple 
replicates. 
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results suggest that glycosylation of nsp4 is important for nsp4 function during virus 
replication.  
 
Nsp4 glycosylation mutants have reduced viral RNA synthesis 
Since previous studies have shown that mutations in nsp4 affect viral RNA 
synthesis (Sparks, Lu, and Denison, 2007), experiments were conducted to determine if 
the growth defects of nsp4 glycosylation mutants were associated with changes in viral 
RNA synthesis (Fig. 4.4).  DBT cells were mock-infected or infected with wt, N176A, 
N237A, or N176A/N237A mutant viruses at an MOI of 5 PFU/cell to maximize single 
round infection, and infected cells were metabolically labeled with [3H]uridine in the 
presence of actinomycin D for 2 h intervals from 3 to 15 h p.i.  Total RNA was extracted 
from harvested cells and measured for incorporation of [3H]uridine.  Peak incorporation 
of [3H]uridine for wt MHV occurred from 9 to 11 h p.i., similar to a previously published 
report (Graham and Denison, 2006). For all three nsp4 mutant viruses, peak incorporation 
was delayed compared to wt, occurring between 11 and 13 h p.i.  
Delays in the timing of peak viral RNA synthesis displayed by the nsp4 
glycosylation mutant viruses were also associated with decreases in the amount of RNA 
synthesized over the course of the infection. The N176A mutant virus synthesized 
approximately 80% of the maximum amount of incorporation seen for wt over a 2 h 
labeling period.  Both the N237A and the N176A/N237A mutant viruses exhibited a 50% 
reduction in peak viral RNA synthesis.  These data demonstrate that there is an overall 
decrease in viral RNA synthesis in the nsp4 mutant viruses compared to wt virus.  In 
addition, the delay and decrease in RNA synthesis correlated with the kinetics and peak  
 83 
 
 
Fig. 4.4.  RNA synthesis of nsp4 glycosylation mutant viruses.  DBT cells in 6-
well plates were mock-infected or infected with wt, N176A, N237A, or 
N176A/N237A viruses at an MOI of 5 PFU/cell.  Cells were treated with 
Actinomycin D for 30 min prior to addition of radiolabel.  Cells were 
metabolically labeled with [3H]uridine for the intervals indicated, cells were 
lysed, and [3H]uridine incorporation was quantified by liquid scintillation 
counting of TCA-precipitable RNA.  Data points represent the mean 
counts/minute (cpm) of two individual experiments, and error bars represent the 
standard deviations between two experiments. 
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titer of infectious viruses, suggesting that alteration of viral RNA synthesis was 
responsible for the growth defects from the N176A and N237A substitutions.  
 
Removal of nsp4 glycosylation sites does not alter nsp4 localization 
Nsp4 colocalizes with other replicase nsps in cytoplasmic replication complexes 
that are sites of viral RNA synthesis, and nsp4 has been predicted to be critical for 
formation of these complexes.  To test if altered RNA synthesis resulting from the 
N176A and N237A substitutions was associated with altered nsp4 interactions with other 
replicase proteins, the localization of nsp4 was compared by immunofluorescence with 
nsp8, a well described marker for replication complexes, and with the viral membrane 
protein (M), a marker for sites of virus assembly in the ERGIC and Golgi and distinct 
from replication complexes.  DBT cells on glass coverslips were infected with wt, 
N176A, N237A or N176A/N237A viruses for 6 hours, fixed, and probed for nsp4, nsp8, 
and M.  For wt and all nsp4 mutant viruses, nsp4 colocalized extensively with nsp8 in 
punctate perinuclear and cytoplasmic foci (Fig. 4.5A).  However, there was a visual trend 
for fewer and less intense fluorescent foci in the cells infected with the nsp4 mutants 
compared to wt virus, suggesting that there may be fewer forming or altered replication 
complexes in the nsp4 mutant virus infections (Fig. 4.5A and data not shown). When 
nsp4 was compared with M (Fig. 4.5B), wt and mutant viruses had identical patterns of 
non-colocalization of nsp4 with M, consistent with previous studies of MHV replicase 
proteins and indicating that nsp4 is not altered in its relationship to sites of assembly and 
not localized to the ERGIC or Golgi.  The results demonstrate that nsp4 mutant viruses  
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Fig. 4.5.  Immunofluorescence of nsp4 localization.  DBT cells on glass coverslips were 
infected with the indicated viruses at an MOI of 10 PFU/cell.  At 6 h p.i., cells were fixed 
and probed with antibodies to nsp4, nsp8, and membrane (M) protein and analyzed by 
immunofluorescence using a Zeiss Axiovert 200 microscope at 40× magnification.  A) Nsp4 
colocalizes with nsp8.  Infected cells were analyzed by indirect immunofluorescence using 
α-nsp4 (Alexa 488-green) and direct immunofluorescence by Alexa 546 conjugated to α-
nsp8 (red).  Yellow pixels represent colocalization of overlapping green and red pixels.  B) 
Nsp4 does not colocalize with M protein.  Infected cells were probed by indirect 
immunofluorescence using rabbit α-nsp4 (green) and mouse α-M (red).  The scale bar in the 
upper images in panels A and B equals 20 µM and is representative of all other images. 
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are able to form cytoplasmic replication complexes and retain interactions with other 
replicase nsps and that glycosylation of nsp4 is not required for this process. 
 
Nsp4 glycosylation mutant viruses induce altered  
membrane rearrangements and irregular DMVs 
Based on the replication defects and subtle visual variability observed during 
immunofluorescence analysis of nsp4 mutants, experiments were performed that next 
investigated whether the nsp4 glycosylation mutants have altered membrane 
rearrangements.  Transmission electron microscopy (TEM) was used to visualize the 
ultrastructure of membrane modifications in infected cells.  DBT cells were mock-
infected or infected with wt or the nsp4 glycosylation mutant viruses at an MOI of 5 
PFU/cell.  At 6 h p.i., cells were fixed in 2% glutaraldehyde and processed for TEM 
analysis.  For mock-infected cells, the cellular architecture and organelle morphology 
was intact (Fig. 4.6A).  Cells infected with wt virus exhibited clearing of cytoplasmic 
contents and swollen ER and Golgi (Fig. 4.6B). Cells infected with the three nsp4 
glycosylation mutant viruses also demonstrated swelling of ER and Golgi and 
cytoplasmic clearing, albeit less so than during wt infection (Fig. 4.6C-E).   
In contrast, there was a striking difference between cells infected with wt and 
nsp4 mutants in the relationship and ultrastructure of virus-induced DMVs and 
convoluted membranes (CMs). WT- and nsp4 mutant-infected cells exhibited virus-
induced CMs and DMVs, structures that have been identified in replication complexes 
and associated with viral RNA synthesis (Gosert et al., 2002; Knoops et al., 2008), while 
no DMVs or CMs were observed in mock-infected cells. CMs were detected in wt and  
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Fig. 4.6. EM analysis of replication complexes and DMVs from wt and nsp4 mutants.  DBT 
cells were mock-infected or infected with wt, N176A, N237A, or N176A/N237A viruses.  Cells 
were harvested in 2% glutaraldehyde and processed for TEM analysis. A and A1) Mock-infected 
cells.  B and B1) wt MHV infection.  C and C1) N176A mutant virus infection.  D and D1) 
N237A and E and E1) N176A/N237A mutant virus infections. Dotted boxes in the left image 
indicate area of magnification in right image.  The scale bar in the left images represents 500 nm.  
Arrowheads indicate dark-stained, individual virions, which are located above the arrowheads.  
Black arrows point to CMs.  * indicates examples of regular DMV structure.  ⊗ shows examples 
of irregular DMV structure.  N, nucleus; ER, endoplasmic reticulum; G, Golgi apparatus; M, 
mitochondria; CM, convoluted membranes.  
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mutant virus-infected cells and always in close proximity of DMVs.  However, DMVs 
were observed in the presence or absence of CMs for all viruses.  The CMs were 
observed more frequently in EM sections of cells infected with N176A, N237A, and 
N176A/N237A mutant viruses compared to wt (Fig. 4.6C, 4.6D, 4.6E). The vast majority 
of DMVs in wt-infected cells exhibited characteristic DMV morphology of a circular 
shape, regular diameter, and ultrastructure of closely approximated inner and outer 
membranes.  A small subset of DMVs manifested a partial separation of the inner and 
outer membranes and exhibited a slightly larger diameter, but these were rare. In contrast, 
cells infected with the nsp4 glycosylation mutants demonstrated DMVs with altered 
shape and diameter and with increasingly aberrant (irregular) ultrastructure, consisting of 
severely detached and collapsed inner membranes that was not observed in any wt-
infected cells.  The number of irregular DMVs and extent of DMV derangement was 
most profound in N237A and N176A/N237A mutant-infected cells and visibly greater 
than that detected in cells infected with N176A alone.  
 Because the EM images were originally selected based on the detection of DMVs, 
EM images were selected and used to quantitatively compare: 1) prevalence of CMs; 2) 
ratio of regular (wt-like) and irregular DMVs; and 3) the diameter of regular and irregular 
DMVs (Table 4.2 and Fig. 4.7). Since the images were selected only for presence of 
DMVs, the quantitative analysis that was performed was unbiased for these specified 
parameters. The prevalence of CMs was determined by comparing images where CMs 
were observed or not observed in EM sections selected based on the presence of DMVs, 
since CMs were only found in the presence of DMVs.  While there was no statistical 
difference between wt and N176A in the ratio of sections with both CMs and DMVs  
 90 
 
T
ab
le
 4
.2
. 
 A
n
al
y
si
s 
o
f 
V
ir
u
s-
In
d
u
ce
d
 M
em
b
ra
n
e 
S
tr
u
ct
u
re
s 
V
ir
u
s 
T
o
ta
l 
C
el
l 
S
e
ct
io
n
s 
w
it
h
 E
v
id
en
ce
 o
f 
In
fe
ct
io
n
 
S
ec
ti
o
n
s 
w
it
h
 C
M
s 
a
n
d
 
D
M
V
s 
S
ec
ti
o
n
s 
w
it
h
 D
M
V
s 
O
n
ly
 
T
o
ta
l 
D
M
V
s 
C
o
u
n
te
d
 
R
eg
u
la
r 
D
M
V
s 
Ir
r
e
g
u
la
r 
D
M
V
s 
A
v
er
a
g
e 
R
eg
u
la
r
 D
M
V
 
D
ia
m
et
e
r 
(n
m
) 
A
v
er
a
g
e 
Ir
r
e
g
u
la
r 
D
M
V
 
D
ia
m
et
e
r 
(n
m
) 
W
T
 
2
4
 
8
 
1
6
 
1
0
2
 
8
6
 
1
6
 
2
5
5
.2
 ±
 3
1
.4
 
3
2
3
.2
 ±
 3
5
.6
 
N
1
7
6
A
 
2
1
 
1
1
 
1
0
 
1
2
7
 
9
6
 
3
1
 
2
5
7
.0
 ±
 5
2
.3
 
3
2
4
.2
 ±
 3
1
.8
 
N
2
3
7
A
 
1
1
 
9
 
2
 
7
2
 
3
6
 
3
6
 
2
6
4
.6
 ±
 5
3
.6
 
3
7
2
.5
 ±
 4
1
.6
 
N
1
7
6
A
/N
2
3
7
A
 
2
1
 
1
8
 
3
 
1
1
7
 
6
0
 
5
7
 
2
7
0
.4
 ±
 5
6
.1
 
3
7
1
.3
 ±
 4
1
.6
 
 
 91 
 
 92 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.7.  Quantitative analysis of CMs and DMVs.  A) CMs and DMVs.  All EM images 
were analyzed for the presence of CMs and DMVs based on characteristic EM morphology. 
Because CMs were only found in the presence of DMVs in all TEM sections observed, the 
ratio of total cell sections with CMs + DMVs could be compared to the presence of cell 
sections with DMVs alone. Black bars indicate presence of both CMs and DMVs, while white 
bars represent the presence of DMVs alone.  Chi square analysis was used to compare the 
presence of CMs + DMVs to DMVs alone.  B) Ratios of DMVs with regular morphology 
compared to total DMVs (regular + irregular).  Total DMVs and DMVs with regular 
morphology were counted for all viruses in TEM images and the ratio of regular DMVs to total 
DMVs was determined.  C) Diameter of regular and irregular DMVs of wt and nsp4 
mutants.  DMVs were measured in Image J by the widest diameter in nm of outer membranes.  
Black bars indicate regular DMVs, while white bars indicate irregular DMVs. Error bars 
indicate standard deviation.  There was no significant difference (not labeled in the figure) in 
diameter of regular DMVs between wt and nsp4 mutant viruses.   ANOVA followed by Tukey 
tests indicated a significant difference in the diameter of irregular DMVs of the N237A and 
N176A/N237A viruses compared to both wt and N176A viruses.  * (p < 0.05), ** (p<0.01), 
and *** (p,0.001) indicates levels of statistical significance compared to wt virus.  NS, no 
significance. 
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versus DMVs alone, the N237A and N176A/N237A mutants had significantly increased 
ratios of detection of both CMs and DMVs compared to DMVs alone (p<0.01 for N237A 
and p<0.001 for N176A/N237A) (Fig. 4.7A).  Analysis of the ratio of regular DMVs to 
total DMVs (regular + irregular) demonstrated a significant increase in irregular DMVs 
in cells infected with N237A and N176A/N237A mutant viruses (p < 0.001) when 
compared to cells infected with wt or N176A viruses (Fig. 4.7B).  The observations also 
revealed more irregular DMVs in N176A than wt, but the regular DMV/total DMV ratios 
were not significantly different. Finally, the measurement of regular DMVs of both wt 
and all nsp4 glycosylation mutant viruses revealed no difference in their diameters 
(widest diameter of outer membrane) (Fig. 4.7C).  In contrast, the mean diameter of 
irregular DMVs in the N237A and N176A/N237A mutant viruses was significantly 
greater than that of either wt virus or the N176A mutant virus (Fig. 4.7C).  This analysis 
indicates that nsp4 is likely critical for the organization and stability of DMVs and for the 
relationship and evolution of membrane modifications (CMs and DMVs) over the course 
of infection. 
 
Discussion 
Although multiple studies have investigated the roles of nonstructural proteins in 
inducing membrane rearrangements, understanding the role of glycosylation of 
nonstructural proteins from positive-strand RNA viruses remains limited.  A study of the 
flavivirus yellow fever virus demonstrated that NS1 glycosylation was important for 
several functions in the virus life cycle (Lindenbach and Rice, 1999; Muylaert et al., 
1996).  NS1 interacts with membranes and is involved in replicase function (Lindenbach 
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and Rice, 1999), and removal of NS1 glycosylation by asparagine-to-alanine substitution 
results in impaired virus growth, RNA synthesis, and pathogenesis (Muylaert et al., 
1996).  
Coronaviruses, like other positive-strand RNA viruses, induce the formation of 
DMVs that serve as scaffolds for replication/transcription complexes.  Exogenous 
expression of the poliovirus transmembrane proteins 2BC and 3A results in DMVs that 
are indistinguishable from those formed during wt infection (Schlegel et al., 1996; Suhy, 
Giddings, and Kirkegaard, 2000).  Equine arteritis virus (EAV), which is classified with 
coronaviruses in the order Nidovirales, induces DMVs similar to coronaviruses (Pedersen 
et al., 1999).  Exogenous plasmid expression of EAV nsp2 and nsp3 is sufficient to 
induce membrane modifications resulting in membrane structures similar to those seen 
during EAV infection, and mutations within EAV nsp3 also result in altered virus-
induced membrane rearrangements (Posthuma et al., 2008; Snijder et al., 2001).  EAV 
nsp3 is a tetra-spanning integral membrane protein implicated in DMV formation and 
organization.  Of interest, an introduced Asn substitution (T873N) in an EAV nsp3 
luminal domain resulted in nsp3 glycosylation in vitro, but was highly detrimental when 
introduced into the genome and only recovered as a pseudoreversion (N873H) that 
abolished the glycosylation site. Thus for another nidovirus, the glycosylation status of a 
membrane modifying replicase protein is also important for DMV formation and RNA 
synthesis during virus replication.  
This report confirms multiple roles of MHV nsp4 in the virus life cycle, including 
optimal virus replication, RNA synthesis, and its importance in the modification and 
morphology of virus-induced membrane structures. In this study, it was shown that MHV 
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nsp4 is glycosylated and functions as a membrane modification protein that regulates 
virus-induced membrane rearrangements.  Nsp4 glycosylation mutant viruses display 
highly irregular DMVs and an increased prevalence of CMs relative to DMVs alone.  The 
extent of disrupted DMVs in the nsp4 glycosylation mutant viruses correlated directly 
with decreases in RNA synthesis and virus replication.  These data suggest that altered 
membranous structures from the nsp4 glycosylation mutants result in a reduced capacity 
to synthesize viral RNA or protect viral RNA from degradation, ultimately leading to 
impaired virus fitness. 
Previous studies have concluded that nsp4 is required for MHV replication and 
have identified determinants of membrane topology, subcellular localization, and 
function (Clementz et al., 2008; Oostra et al., 2007; Sparks, Lu, and Denison, 2007).  
This study is the first to recover and characterize the importance of multiple nsp4 
glycosylation events on virus replication, viral RNA synthesis, and virus-induced 
membrane modifications during coronavirus infection.  Clementz et al. recovered an nsp4 
N176A mutant, but were unable to recover an N237A or N176A/N237A mutant 
(Clementz et al., 2008).  Their N176A mutant grew with similar kinetics to wt at an MOI 
of 0.1 PFU/cell at 33oC and 39oC, but was not further characterized in that report.  In 
contrast to the previously published report, the N237A and N176A/N237A mutant 
viruses were able to be recovered and characterized.  The reasons for the differences in 
recovery can only be speculated. The background of cloned MHV genome fragments 
should be identical since the MHV genome fragments were jointly developed with the 
Denison lab and the Baric lab. In addition, I performed RT-PCR sequencing of the 
complete genome from the recovered N176A/N237A mutant virus, which verified the 
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engineered mutations and also confirmed that the rest of the genome was identical, with 
no additional mutations of any kind, to the published recombinant MHV-A59 sequence.  
Thus, there were no other compensating mutations to account for or consider for the 
recovery of the mutant virus.  The lab has also experienced occasional mutations in the 
genome fragments during preparation for genome assembly that have prevented recovery 
of even known viable mutants and would therefore speculate that this could account for 
the non-recovery of N237A and N176A/N237A mutant viruses by Clementz et al. These 
results clearly demonstrate that the N176 and N137 residues and the associated 
glycosylation events are not required for MHV replication in cell culture.  Since no other 
mutations were identified in the genome RNA from the recovered N176A/N237A mutant 
virus, it can be concluded that the profound and distinct phenotypes in virus replication, 
RNA synthesis, and virus-induced cellular membrane modifications are due to the 
introduced mutations alone. 
 Potential functions of nsp4 glycosylation.  Modification of proteins by addition 
of N-linked glycans may result in numerous effects on protein functions (Fiedler and 
Simons, 1995; Helenius and Aebi, 2001).  Therefore, glycosylation of nsp4 may be 
important for a variety of reasons.  One potential mechanism of nsp4 glycosylation is 
proper protein folding (Helenius, 1994; Paulson, 1989).  By removing N-linked glycans, 
the overall structure of nsp4 may be altered during protein folding.  This mechanism is 
supported by the findings in this report in that the nsp4 glycosylation mutant viruses 
displayed impairments in virus replication, viral RNA synthesis, and virus-induced 
membrane modifications.  Other explanations are possible for the role of nsp4 
glycosylation on replication complex formation and membrane modifications.  For 
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instance, glycosylation of nsp4 may be important for protein stability and prevention of 
nsp4 degradation (Klausner and Sitia, 1990).  Lastly, it is possible that the N-linked 
glycans, either directly or through modification of nsp4 structure, recruit cellular factors 
that are involved in membrane rearrangements.  Future studies are needed to distinguish 
between these possibilities. 
 Models of nsp4 function on replication complex formation, morphology, and 
organization.  Evidence from this study has led to potential models addressing the effect 
nsp4 has on replication complex formation, morphology, and organization. One possible 
model is that nsp4 may regulate the transition or formation of different membrane 
modifications (i.e. CMs and DMVs).  The evidence from this report in that there was an 
increased prevalence of CMs in relation to DMVs in the N237A and N176A/N237A 
mutant viruses suggests that MHV nsp4 may be a major player in the transition of these 
virus-induced membrane rearrangements from one membrane structure to another. Other 
findings in that there was an increased presence of aberrant or deranged DMVs in the 
N237A and N176A/N237A mutant viruses from this report suggests another possibility 
in that the formation of intact, functional DMVs is regulated by nsp4.  
A second potential model of nsp4 function is that the curvature and size of DMVs 
are regulated by nsp4 (Perlman and Netland, 2009).  In N237A and N176A/N237A 
mutant virus-infected cells, irregular DMVs were much larger and had highly disrupted 
inner membranes.  The N237A and N176A/N237A mutant viruses also exhibited 
decreases in RNA synthesis, indicating that these irregular DMVs may not be functioning 
properly and that curvature and size may be important for proper function.  This model is 
supported by the fact that all virus-infected cells produced regular DMVs, although at 
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different proportions, and that all regular DMVs were similar in size.  Cells infected with 
wt or N176A viruses, those that had higher levels of RNA synthesis compared to the 
N237A and N176A/N237A mutant viruses, also had a higher percentage of regular 
DMVs.  These data suggest that curvature and size are important for DMV function.  
A third model is that nsp4 functions in tethering or “pushing” the inner membrane 
to the outer membrane of the DMVs.  The proximity of the inner membrane to the outer 
membrane may be important for creating an environment optimal for RNA synthesis 
and/or protection of newly synthesized viral RNAs.  This model is supported by the fact 
that the prevalence of aberrant DMVs in the nsp4 glycosylation mutants was directly 
related to the extent of impairment of RNA synthesis and virus growth. These results 
suggest that irregular DMVs have a reduced capacity to synthesize and/or protect viral 
RNAs and are also the first to provide direct evidence suggesting that the physical size, 
morphology, and stability of virus-induced DMVs is important for efficient viral RNA 
synthesis and optimal virus production.  On the other hand, the results also show clearly 
that glycosylation of nsp4 is not absolutely required for formation of  “regular” DMVs, 
and that replication complex function can still ultimately allow virus replication to wt 
titers, albeit with delayed kinetics.   
To date, all coronavirus nsp4s that were subjected to Endo H treatment have been 
shown to be glycosylated in the lumen of the ER between the first and second predicted 
transmembrane domains of nsp4 in exogenous expression experiments, including group 
2a MHV nsp4, group 2b SARS-CoV nsp4, and group 3 IBV nsp4 (Clementz et al., 2008; 
Lim, Ng, and Liu, 2000; Oostra et al., 2007).  It will be interesting to see whether 
glycosylation of nsp4 is conserved among other coronaviruses, specifically group 1 
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coronaviruses, and what effect the loss of glycosylation sites has on virus replication, 
RNA synthesis, and replication complex morphology.  Finally, it will also be intriguing 
to determine if other nonstructural proteins from coronaviruses and other RNA viruses 
are glycosylated and what effects glycosylation has on the individual protein’s 
function(s). 
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CHAPTER V 
 
SUMMARY AND FUTURE DIRECTIONS 
 
Introduction 
 At the start of this dissertation, research in coronavirus biology was expanding 
rapidly, and research efforts were increasing dramatically due to two key events.  The 
establishment of reverse genetics systems for coronaviruses and the outbreak of a new 
human coronavirus that caused severe disease served as the dominant forces for an 
extraordinary push in understanding coronavirus replication and biology.  Within recent 
years, multiple investigators have contributed to our increased knowledge of many 
aspects of coronavirus biology. 
 It was within this resurgence of research that I began my graduate studies.  Prior 
to the invention of reverse genetics systems for coronaviruses, studies of the coronavirus 
replicase were largely limited to the use of biochemical and cell imaging experiments for 
the identification and analysis of intermediate and mature replicase proteins.  While these 
studies were critical in the identification of CSs, protein detection and analysis, and 
localization studies, it was not possible to address the effects of cleavage events and 
functions of replicase proteins on virus replication.  Through the utilization of a powerful 
reverse genetics system for MHV, my research addressed multiple questions to ultimately 
lead to a better understanding of how coronaviruses replicate in host cells.  Specifically, 
my research has increased our understanding of the mechanisms and requirements of 
polyprotein processing, the evolution of PLP-mediated processing of nsps 1-4 of 
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coronaviruses, the importance of coronavirus genome organization, and the discovery of 
specific functions of replicase proteins during virus replication.  The findings from my 
research have opened new areas to explore in the coronavirus field, as well as in the 
discipline of RNA viruses.  This chapter will summarize the main findings of this 
dissertation, highlight recent advances, and engage in the new and interesting ideas, 
questions, and potential future work generated from this graduate research. 
 
Effects of encoding nsp2 at different genomic loci 
 Prior to my work on alternate expression studies of MHV nsp2, a published report 
from the lab had shown that the nsp2 coding sequence and protein is dispensible for virus 
replication of both MHV and SARS-CoV (Graham et al., 2006).  The deletion of the nsp2 
domain of the MHV and SARS-CoV replicase polyproteins resulted in a 90% reduction 
in growth and a 50% reduction in RNA synthesis.  Although nsp2 is the most variable 
replicase protein across coronaviruses, the deletion of nsp2 from both MHV and SARS-
CoV resulted in similar effects on virus growth, RNA synthesis, and protein processing 
phenotypes, suggesting that the nsp2 sequences evolved or adapted to have similar 
functions in virus replication.  These results also demonstrated that there is considerable 
flexibility for mutations and reorganization of the coronavirus genome. 
 The goal of my project was to determine whether expression of nsp2 from non-
native sites in the coronavirus genome could complement the replication defect of a virus 
lacking nsp2 in its native context, in order to test the hypothesis that the context and 
levels of expression of nsp2 are essential for optimal replication, its localization, and its 
function .  Therefore, the nsp2 coding sequence was engineered into alternative locations 
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of the MHV genome, both in the presence and absence of the native-expressed nsp2 
coding sequence.  Multiple sites were chosen to introduce the nsp2 coding region, and the 
introduction of the nsp2 sequence resulted in both viable and nonrecoverable mutant 
viruses.  Moreover, none of the alternate-encoding nsp2 viruses complemented the 
growth defect observed with the mutant MHV Δnsp2 virus.  Interestingly, overexpression 
of nsp2 by encoding it at two locations in the genome, one copy at its native location and 
the other in place of ORF4, was detrimental to virus replication and altered nsp2 
localization, where nsp2 was still localized to punctate perinuclear foci but was also 
diffusely distributed throughout the cytoplasm. 
 The results generated from this study demonstrate that nsp2 expressed from its 
native location in the genome is required for optimal MHV replication.  Native 
expression of nsp2 may be important for a variety of reasons.  It is possible that the nsp2 
RNA coding sequence provides stability to the genome, preventing its degradation.  
Secondly, the nsp2 coding sequence may recruit other factors that are important in 
regulation of transcription or translation during the virus life cycle.  A more likely model 
is that the known nsp2-3 precursor that is detected during virus infection plays a role in 
the timing and/or regulation of virus replication.  Abolition or impaired cleavage between 
nsps 2-3 results in a virus with significant delays in exponential growth.  My results 
support the conclusion that proper nsp2 function may depend on being expressed as an 
nsp2-3 intermediate protein prior to processing and that the sequential order of processing 
likely has specific functions that have not yet been characterized. 
 Finally, this study resulted in additional questions that my graduate research 
aimed to address.  While addition of residues at the N-terminus did not affect growth and 
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protein processing, addition of LeuGln residues at the C-terminus of nsp2 resulted in 
delays in virus growth and protein processing.  Because LeuGln amino acids, key 
residues in nsp5 recognition and cleavage, were added downstream of the native CysAla 
amino acids, key residues recognized by PLP1, it is not known which protease was 
mediating processing at the engineered site.  This gave rise to several interesting 
questions, including:  (1) which protease is responsible for cleaving altered CS2?; (2) 
how much flexibility is there in the amino acid sequences upstream and downstream of 
CSs that will still allow processing?; (3) are proximal CS amino acid residues all that are 
necessary for protease recognition and processing?; and (4) can viral protease recognition 
and processing be switched by altering CS amino acid sequences?  My next project aimed 
at understanding the requirements for protease recognition and processing at CSs. 
  
Rewiring the MHV replicase polyprotein to function with one PLP 
 The research described above and previous studies of coronaviruses have 
analyzed the effects of CS mutations and deletions in the replicase polyprotein on virus 
replication, protein processing, and RNA synthesis.  Recently, our lab and others have 
shown that catalytic activity of MHV PLP1 and HCoV-229E is not absolutely required 
for virus viability and replication (Graham and Denison, 2006; Ziebuhr et al., 2007).  
While PLP1 catalytic activity is not required for virus replication, the overall effects of 
PLP1 catalytic inactivation were remarkably different when comparing the two viruses.  
For MHV, the catalytic inactivation of PLP1 resulted in a severely debilitated mutant 
virus that only reached peak titers of ~103 PFU/ml and exhibited no processing at CS1 
and CS2.  On the other hand, the inactivation of PLP1 from HCoV-229E resulted in a 
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virus that grew only 2 log10 PFU/ml less than wild-type HCoV-229E.  Also, HCoV-229E 
PLP2 was capable of processing at CS1, CS2, and CS3, unlike that of MHV PLP2, which 
only processes at CS3.  Because the first three CS amino acid sequences are divergent for 
MHV and are similar for HCoV-229E and other coronaviruses that encode only one PLP, 
it was predicted that the CS amino acid sequence controls the requirement of encoding 
one or two catalytically active PLPs. 
 The second goal of my research was to test the hypothesis that the proximal CS 
amino acid sequences are sufficient for protease recognition and processing and whether 
protease specificity could be switched from PLP1 to PLP2 by substituting the proximal 
CS amino acid sequences.  The MHV PLP2 CS recognition sequence P4-LXGG-P1 was 
introduced in place of CS1 and/or CS2 in the presence or absence of catalytically active 
PLP1.  Viable viruses were recovered and protein expression studies demonstrated that 
PLP2 can process downstream of LXGG amino acid sequences at CS2; however, there 
was no detectable processing at the first CS that was substituted with LXGG.  These 
findings indicate that the LXGG amino acid motif is necessary for processing by PLP2, 
but other factors are also required for efficient PLP-mediated processing of nsps 1-3.
 The potential factors that may be required for efficient processing are highlighted 
in Fig. 5.1.  One potential factor is that the recognition sequence of MHV PLP2 requires 
more than the LXGG motif.  Amino acids upstream and/or downstream of this motif may 
be necessary for optimal recognition, binding, and processing by PLP2.  A previous study 
that identified the third CS of MHV also showed that the P6 residue upstream of the CS 
may be important for PLP2 recognition and processing in vitro (Kanjanahaluethai, 
Jukneliene, and Baker, 2003).  Secondly, proteolytic processing at CS1 and/or CS2 may
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Fig. 5.1.  Proposed models of inefficient proteolytic processing at substituted CSs.  During 
wild-type MHV processing of nsps 1-3, PLP1 mediates efficient processing at both CS1 and CS2.  
When CS1 or CS2 was replaced with the PLP2 L-X-G-G recognition motif, there was either no or 
reduced processing observed at the mutated CSs.  The three proposed models of inefficient 
processing are shown.  (1) Amino acids directly upstream and/or downstream of the PLP2 
recognition sequence are required for efficient protein processing.  (2)  After translation or by 
interactions of amino acids upstream and/or downstream of the mutated CS, PLP1 blocks the CS, 
inhibiting PLP2 from accessing the CS.  (3)  Due to other constraints within nsps 1-3, PLP2 is 
blocked from accessing the mutated CSs.  PLP1 is shown as a blue triangle, and its CSs are shown 
in blue.  PLP2 is shown as a red rectangle, and its CSs are linked in red.  Models are shown as 
trans-cleavage models for simplification. 
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occur fully or partially by cis-cleavage.  After translation of the N-terminal replicase 
polyprotein, MHV PLP1 may be in close association with CS1 and/or CS2.  This could 
potentially block or inhibit the recognition and cleavage by PLP2 at substituted LKGG 
amino acid motifs at these locations.  Lastly, instead of PLP1 blocking proteolytic 
cleavage, inefficient processing may be due to structural constraints within nsps 1-3 that 
do not allow access of the CS recognition sequence into the PLP2 catalytic site.  These  
structural constraints may be due to protein folding of a hypothetical nsp1-2 intermediate 
or possibly to the location of PLP2 within nsp3.  The likelihood that multiple factors play 
a role in processing of nsps 1-3 is highly likely, and potentially all three of these 
proposed factors, and possibly factors not mentioned, play a role in optimal protein 
processing.  
 To better understand the evolutionary relationships and protein processing of 
coronavirus PLPs, mutations were engineered into MHV so that the organization of 
MHV nsps 1-3 would be similar to that of SARS-CoV.  Although the engineered virus 
had similar CS amino acid sequences and only one catalytically active PLP, the 
engineered MHV mutant was debilitated in growth, indicating that engineered CS and 
PLP organization of MHV similar to SARS-CoV is detrimental for virus replication.  
These data also suggest that coronavirus nsps 1-3 have evolved to function cooperatively.  
The observed significant variability in nsps 1-3 across divergent coronaviruses and 
evidence for rapid evolution in SARS-CoV nsps 1-3 during the epidemic both support 
this possibility.  This concept will be discussed further under future studies later in this 
chapter.  
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Role of nsp4 in the coronavirus life cycle 
 Prior to my work studying MHV nsp4, it was known that nsp4 demonstrated 
characteristics of an integral membrane protein (Gosert et al., 2002).  It was also 
predicted that nsp4 likely plays a key role in virus-induced membrane modifications 
(Perlman and Netland, 2009).  A recent study from our lab demonstrated that nsp4 is 
required for production of infectious virus, and mutations within nsp4 result in decreased 
RNA synthesis (Sparks, Lu, and Denison, 2007).  Additionally, it was shown that 
plasmid-expressed nsp4 is glycosylated in transfected cells (Clementz et al., 2008; Oostra 
et al., 2007); however, it was not known if nsp4 was glycosylated during infection and 
what effects glycosylation may have on nsp4 function. 
 The main focus of my research was to test the hypothesis that nsp4 serves critical 
functions in the formation and function of replication complexes that are located on 
double membrane vesicles (DMVs).  In addition, I sought to determine whether nsp4 is 
glycosylated and if nsp4 glycosylation is required for nsp4 function(s).  Mutant viruses 
were generated with mutations at nsp4 residues N176, N237, or both to test the effects of 
these mutations on growth, RNA synthesis, nsp4 glycosylation, and nsp4 localization.  
MHV nsp4 was shown to be glycosylated at residues N176 and N237.  The three nsp4 
glycosylation mutant viruses, N176A, N237A, and N176A/N237A, all exhibited defects 
in virus growth and RNA synthesis.  The N237A and N176A/N237A displayed growth 
and RNA synthesis defects that were greater than that of the N176A mutant virus.  
Transmission electron microscopic analysis of ultrastructure from infected cells 
demonstrated that the nsp4 mutants had aberrant morphology of virus-induced DMVs 
when compared to those infected with wt virus, with the N237A and N176A/N237A 
 108 
having severely disrupted DMVs.  Interestingly, the degree of altered DMV morphology 
directly correlated with the reductions in viral RNA synthesis and virus growth observed 
for the nsp4 mutant viruses. The results demonstrate that nsp4 plays a critical role in the 
organization and stability of DMVs and suggest that N176 and N237 play specific roles 
in nsp4 membrane modifications and stability. The results also support the concept that 
the formation and physical structure of DMVs is essential for efficient RNA synthesis 
and optimal replication of coronaviruses. 
 While the exact function(s) of nsp4 remain to be elucidated, results from this 
study provide evidence supporting potential mechanisms of the function(s) of nsp4 on 
replication complex formation, organization, and morphology (Fig. 5.2).  One proposed 
model is that nsp4 functions in the regulation or timing of the transition and formation of 
virus-induced membrane modifications.  For example, nsp4 may play a role in the 
transition of convoluted membranes (CMs) to DMVs or from DMVs to CMs.  This 
mechanism of nsp4 is supported by the fact that there was an increased presence of CMs 
in the nsp4 mutant infections compared to wt virus infections.  A second possible model 
is that nsp4 regulates the size and curvature of DMVs.  Because infections with mutant 
nsp4 exhibited DMVs that were larger, wider, and had disrupted inner membranes 
compared to wt infections, nsp4 may function in controlling the shape of virus-induced 
DMVs.  Finally, nsp4 may function in bringing the inner membrane in close 
approximation to the outer membrane, either through “pushing” the inner membrane out 
towards the outer membrane or by a tethering mechanism.  This potential mechanism is 
supported by the fact that DMVs observed in the nsp4 mutant virus infections had 
disrupted and collapsed inner membranes compared to DMVs from wt infection.   
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Fig. 5.2.  Potential mechanisms of nsp4 function(s).  Nsp4 has been proposed to function in the 
formation, organization, and morphology of virus-induced membrane modifications.  The 
findings from this study led to several potential models of nsp4 function.  Nsp4 is shown as a 
green oval.  Membranes are shown as black lines.  (1) Nsp4 may function as a key regulatory 
protein in the transition of virus-induced membrane structures observed during infection.  (2) 
Nsp4 may be crucial for the shape, size, and stability of virus-induced membrane structures.  (3) 
Nsp4 may function in shaping or expanding the inner membrane to the outer membrane.  
Alternatively, nsp4 may function in tethering the inner membrane to the outer membrane. 
DMV 
CM 
nsp4 
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While the exact function(s) of nsp4 have yet to be determined, this report confirms that 
nsp4 is critical in multiple steps of the virus life cycle, likely through modification of 
cellular membranes.  The nsp4 mutant viruses and the experimental approaches generated 
in this study provide powerful tools to further dissect mechanisms of the cell biology and 
replication of coronaviruses. 
 
Implications and potential applications of this research 
 Although the 2002 – 2003 SARS outbreak was short-lived, the recent 
identification of bats as reservoirs for coronaviruses and the discovery of coronaviruses 
causing disease in new host species strongly argue that coronaviruses will remain a threat 
to agriculture and public health (Lau et al., 2005).  Currently, there are no FDA approved 
vaccines for the prevention of human coronavirus infections, and there remain no 
clinically proven treatments for coronavirus infections.  Research presented in this 
dissertation that aims at understanding the cell biology and replication of coronaviruses is 
critical and necessary for the development of antiviral therapies and vaccines to treat and 
prevent diseases, such as SARS. 
 The work presented in this dissertation focused on understanding the mechanisms 
of PLP-mediated processing and analysis of the cleavage products.  PLP-mediated 
processing is common to all coronaviruses and is thought to be required for virus 
replication.  Inhibition of PLP-mediated processing by either catalytic inactivation of the 
specific protease or by altering the CSs recognized by PLPs results in virus replication 
defects.  This makes these proteases ideal targets for small molecule or peptide inhibitors 
that disrupt the proteases’ functions.  Also, either inhibiting or altering cleavage events 
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through reverse genetics approaches provides attractive means for vaccine design.  The 
viral protein nsp4 of coronaviruses is also another attractive candidate for antivirals and 
potential vaccine development.  Because nsp4 exhibits integral membrane characteristics 
and functions as a regulator of virus-induced membrane modifications that is necessary 
for replication, small molecule or peptide inhibitors that disrupt membrane interactions, 
replication complex association, and potential protein/protein interactions could reduce 
virus replication and either block or inhibit the progression and symptoms of disease. 
 Positive-strand RNA viruses have evolved similar strategies to usurp cellular 
components to aid in translation, formation of virus replication complexes, and other 
processes necessary for virus replication.  Therefore, investigating the mechanisms of 
coronavirus replication will also aid in our understanding of the replication strategies 
utilized by other positive-strand RNA viruses. 
 
Future studies:  nsp2 function and replicase organization 
 In order to understand the mechanisms of coronavirus replication, it will be 
necessary to determine the functions of viral replicase proteins in the virus life cycle.  
Research presented in Chapter II has yielded new potential avenues of study.  
Determining the function(s) of nsp2 will be challenging since it is a dispensible protein, 
there is no sequence homology to any known proteins, and there are no predicted 
functions.  However, it is known that nsp2 localizes to replication complexes and deletion 
of nsp2 results in reduced viral RNA synthesis and growth.  In an nsp2 deletion mutant, 
replication complexes appear identical to those observed in wild-type infection.  This 
suggests that nsp2 may be a modulatory or an adapter protein that interacts with other 
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nsps and influences viral RNA synthesis, or nsp2 may function in recruitment of cellular 
proteins that optimize RNA synthesis or replication complex formation.  Recent evidence 
suggests both of these possibilities.  A recent study analyzing the intraviral protein-
protein interactions of SARS-CoV showed that nsp2 co-immunoprecipitates with other 
nsps, including nsp3, nsp4, nsp6, nsp8, nsp11, and nsp16 (von Brunn et al., 2007).  The 
multitude of interactions suggests that nsp2 functions as a link to and between other nsps.  
Evidence from our laboratory also shows that exogenously expressed nsp2 is diffuse 
throughout the cytoplasm of transfected cells (Graham et al., 2005); however, upon 
infection of MHV lacking nsp2, exogenous nsp2 relocalizes to replication complexes, 
also suggesting a function in intraviral protein interactions.  Another report has shown 
that SARS-CoV nsp2 also interacts with prohibitin 1 and prohibitin 2 through 
overexpression studies using tagged versions of nsp2 (Cornillez-Ty et al., 2009).  
Prohibitin 1 and prohibitin 2 are evolutionarily conserved proteins and have been 
implicated in multiple cellular processes, including cell cycle progression, cell migration, 
cellular differentiation, apoptosis, and mitochondrial biogenesis.  It will be interesting to 
see if nsp2 interacts with prohibitin and possibly other cellular proteins during 
coronavirus infection.  Also, siRNA knockdown of prohibitin may reveal the potential 
role of nsp2 and prohibitin in virus replication. Because nsp2 has shown to interact with 
multiple proteins and there are no known or predicted functions of nsp2, a solved crystal 
structure of nsp2 may be essential to provide key insights into the possible interactions 
and function(s) of this protein. 
 Because nsp2 is not required for replication, the results presented in Chapter II 
cannot predict the effects of rearrangement of essential replication proteins. However, the 
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report also demonstrated that gene deletions, insertions, and duplications of replicase 
proteins were tolerated in the coronavirus genome, suggesting flexibility in coronavirus 
ORF organization and function.  This study has demonstrated that ORF1b and ORF4 
tolerate insertion of the nsp2 coding sequence, and other studies have shown that other 
nonessential ORFs also tolerate expression of coronavirus and foreign proteins (de Haan 
et al., 2005; Oostra et al., 2007).  Thus, this study provides a platform for the 
investigation into the significance of replicase organization and into the functions and 
placement of essential replicase intermediate and mature proteins in the replicase gene.  
For example, nsp5 (3CLpro) is an essential protein that is first expressed as an nsp4-10 
intermediate protein and is eventually processed into its mature form.  However, it is not 
known whether the placement of nsp5 in the replicase and/or if the nsp4-10 intermediate 
serves key roles in the coronavirus life cycle.  These proposed studies will utilize the 
genomic areas that tolerated sequence deletions and insertions identified from the 
research presented in Chapter II to discover the functions of intermediate and mature 
proteins and the importance of replicase organization of coronaviruses. 
 
Future studies:  plasticity of nsps 1-3 and rewiring replicase CSs 
 The 5’ third of the coronavirus ORF1, encoding nsps 1-3, accounts for the region 
of highest sequence diversity in the replicase across coronavirus groups.  Although there 
is high sequence variability in this region, several reports have shown that nsps 1-3 and 
domains of nsps 1-3 from various coronaviruses in different groups have similar 
functions within the particular host of the specific virus (Barretto et al., 2005; Chen et al., 
2007; Graham et al., 2005; Kamitani et al., 2006; Lindner et al., 2005; Zheng et al., 2008; 
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Zust et al., 2007).  This suggests that nsps 1-3 have acquired sequence diversity, but 
retained similar functions, through evolution and adaptation in their respective hosts.  
Because nsps 1-3 are processed by either one or two PLPs within nsp3, it has been 
proposed that the proteins encoded in this region have coevolved with nsp3 to mediate 
specific functions, such as regulation of cleavage events, within the particular host of the 
coronavirus (de Vries et al., 1997; Ziebuhr, Snijder, and Gorbalenya, 2000; Ziebuhr, 
Thiel, and Gorbalenya, 2001).  Results from Chapter III are consistent with this 
hypothesis in that organization of PLPs and CSs within nsps 1-3 of group 2a MHV which 
mimic those of group 2b SARS-CoV altered protein processing and virus replication. 
These data suggest that coronavirus nsps 1-3 have evolved to function as a cooperative  
unit during virus replication.  In order to determine if nsps 1-3 function cooperatively 
during coronavirus replication, the coding sequence of nsps 1-3 of MHV could be 
replaced with SARS-CoV nsps 1-3 or vice versa (Fig. 5.3).  Because the Denison lab 
possesses reverse genetics systems for both of these viruses, it is possible to test the 
cooperative activity and effects of swapping nsps 1-3 of MHV and SARS-CoV on virus 
replication.  Because studies have shown that nsps 1-3 have similar known and/or 
predicted functions, it is possible that swapping of MHV nsps 1-3 with that of SARS-
CoV nsps 1-3 may have no detrimental effects on virus replication.  On the other hand, 
the swapping of nsps 1-3 may alter virus replication or other known activities, such as 
host mRNA degradation by nsp1, due to adaptation of coronaviruses to their specific 
hosts. 
 Future studies are also needed to address the requirements of PLP-mediated 
processing of coronavirus nsps 1-3.  Results from Chapter III have shown that 
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Fig. 5.3.  Exchange of MHV and SARS-CoV nsps 1-3.  Schematic depicting replicase 
organization of MHV and SARS-CoV.  The replicase organization of MHV and SARS-CoV are 
shown in red and blue, respectively.  In order to determine the cooperative activity of coronavirus 
nsps 1-3, the coding sequence of MHV nsps 1-3 will be switched with SARS-CoV nsps 1-3 and 
vice versa.  S1-3 represents SARS-CoV nsps 1-3, and M1-3 represents MHV nsps 1-3.  The 
hatched box indicates protease domains in both coronaviruses.  The numbers above boxes indicate 
nsp number, and vertical lines indicate cleavage events. 
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requirements or determinants other than proximal CS amino acid sequences are necessary 
for protein processing of nsps 1-3.  A potential approach to better understand the 
mechanisms of coronavirus PLP-mediated processing is to utilize the recovery of key 
mutant viruses, specifically the CS1/2(3) and CS1/2(3)+P1ko viruses, in passage  
experiments.  By passing these CS mutant viruses, mutations may arise in nsps 1, 2, 
and/or 3 that will give insights into the modes of PLP-mediated processing.  The passage 
 experiments will also provide information into the adaptation and evolution of PLPs and 
nsps 1-3 of coronaviruses. 
 Experiments from this dissertation and other reports have shown that CS amino 
acid sequences are important regulators of the processing of intermediate and mature 
proteins of positive-strand RNA viruses (Bedard and Semler, 2004; Lawson and Semler, 
1990; Palmenburg, 1990; Ryan and Flint, 1997; Snijder et al., 1995; Vasiljeva et al., 
2003; Weiss et al., 1994; Ziebuhr, Snijder, and Gorbalenya, 2000).  One potential way in 
which protease recognition and processing can be regulated is by subtle differences in the 
CS amino acid sequences (Table 5.1). Therefore, the binding of a CS and the rate at 
which it is cleaved depends on amino acid residues upstream and downstream of the CS.  
In addition, CS amino acid sequences may be responsible for the production of 
intermediate proteins that are required or beneficial for virus replication.  For instance, 
MHV PLP1 prefers an Arg residue at the P2 position and a small amino acid at the P1 
position.  CS2 is also processed by PLP1, but a Cys is observed in the P2 position 
(Bonilla et al., 1995; Bonilla, Hughes, and Weiss, 1997; Dong and Baker, 1994; Hughes, 
Bonilla, and Weiss, 1995; Teng, Pinon, and Weiss, 1999; Teng and Weiss, 2002).  This 
may be the reason why nsp1 is co-translationally processed and not observed as an nsp1-  
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nsp P4 P3 P2 P1 P1' Protease
1 - 2 G Y R G V PLP1
2 - 3 F P C A G PLP1
3 - 4 L K G G A PLP2
4 - 5 S F L Q S nsp5
5 - 6 V K L Q S nsp5
6 - 7 S Q I Q S nsp5
7 - 8 Q A L Q S nsp5
8 - 9 V V L Q N nsp5
9 - 10 V R L Q A nsp5
10 - 12 S Q F Q S nsp5
12 - 13 A V L Q S nsp5
13 - 14 P R L Q C nsp5
14 - 15 T R L Q S nsp5
15 - 16 P R L Q A nsp5
nsp P4 P3 P2 P1 P1' Protease
1 - 2 L N G G A PLpro
2 - 3 L K G G A PLpro
3 - 4 L K G G K PLpro
4 - 5 A V L Q S nsp5
5 - 6 V T F Q G nsp5
6 - 7 A T L Q A nsp5
7 - 8 L S M Q G nsp5
8 - 9 V K L Q N nsp5
9 - 10 V R L Q A nsp5
10 - 12 P L M Q S nsp5
12 - 13 T V L Q A nsp5
13 - 14 A T L Q A nsp5
14 - 15 T R L Q S nsp5
15 - 16 P K L Q A nsp5
MHV
SARS-CoV
Table 5.1.  Cleavage sites, proteases, and protein processing of coronavirus nsps 1-16.  
The P4 through P1’ amino acids are shown for all cleavage sites in the MHV and SARS-CoV 
replicase polyprotein.  The protease that processes each site is shown to the right.  The arrow 
indicates cleavage.   
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2 or an nsp1-2-3 intermediate.  Also, the lab has discovered another intermediate in virus 
replication, an nsp7-10 intermediate protein.  Instead of a Leu at the P2 position between 
nsp6 and nsp7, an Ile is present at the P2 position.  Interestingly, a Leu is observed at 
almost every other P2 position that is processed by nsp5.  To test whether CS amino acid 
sequences are responsible for the production of intermediate and mature proteins, amino 
acid substitutions can be made at critical residues of the CSs to determine if certain 
residues are necessary for the production of intermediate and mature proteins.  These 
experiments will determine which intermediates are necessary or important in virus 
replication and potentially allow the identification of other intermediate proteins that 
occur during coronavirus replication.  The proposed experiments may also allow for the 
order of replicase protein processing to be determined for coronaviruses.  These 
experiments will provide a better understanding into the regulation of polyprotein 
processing of coronaviruses, as well as establish new methods into the attenuation of 
coronavirus replication.  Finally, these studies will also aid in our understanding of 
polyprotein processing and regulation of mature nsps of other positive-strand RNA 
viruses. 
  
Future studies:  the function(s) of nsp4 in virus-induced membrane modifications 
 While the exact function(s) of nsp4 have yet to be determined, findings from this 
dissertation indicate that nsp4 functions as a regulator of virus-induced membrane 
modifications.  In order to address and determine the specific function(s) of nsp4, a time 
course analyzing ultrastructure of infected cells by EM was performed to uncover the 
function of nsp4 in membrane modifications over the course of an infection.  Because 
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results have shown that the N176A/N237A nsp4 mutant virus exhibited alterations in 
virus-induced membrane modifications compared to wild-type virus at 6 h p.i., the two 
viruses were compared from 2 to 10 h p.i. at 2 h intervals to analyze similarities and 
differences in membrane alterations over the duration of the infection (Fig. 5.4).  At 2 h 
p.i., there was no evidence of infection for both wild-type and the N176A/N237A mutant 
viruses.  While both wild-type and N176A/N237A exhibiting swelling of ER membranes 
at 4 h p.i., only wild-type infected cells exhibited virus-induced CMs and DMVs, 
suggesting that the N176A/N237A mutant exhibits delays in the formation of CMs and 
DMVs.   After 6 h, vesicle packets were observed in wild-type infection, as well as CMs 
and DMVs.  There was also extensive cytoplasmic clearing and disrupted cisternae in the 
mitochondria.  Unlike that of wild-type infection, there were no vesicle packets observed 
and very little cytoplasmic clearing and disrupted mitochondria, also suggesting a delay 
in the timing and production of virus-induced membrane structures.  Also, DMVs 
exhibited separation of inner and outer membranes in the N176A/N237A mutant virus 
infections; however, this appeared to be less pronounced than the previous study from 
Chapter IV.  Also consistent with the findings presented in Chapter IV, the 
N176A/N237A mutant exhibited a qualitative increase in the presence of CMs.  At the 
latest times analyzed by EM, DMVs appear to become unstable and less structured.  
Specifically, DMVs from the N176A/N237A virus infection have lost either their inner or 
outer membrane and appear as single-membraned vesicles at 10 h p.i.    
 These data suggest that nsp4 functions in the stability and formation of virus-
induced membrane structures.  Throughout the time course, the N176A/N237A mutant 
virus appeared to be delayed in virus-induced membrane modifications and cellular  
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Fig. 5.4.  EM time course of virus-induced membrane structures. DBT cells were infected with wt 
or N176A/N237A viruses.  At 2 h intervals, cells were harvested in 2% glutaraldehyde and processed 
for TEM analysis. The scale bar in the images represents 500 nm.  Black arrows point to regular 
DMVs.  Red arrows show examples of irregular DMV structure.  N, nucleus; ER, endoplasmic 
reticulum; M, mitochondria; CM, convoluted membranes; DMV, double membrane vesicle; VP, 
vesicle packet. 
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pathology compared to wild-type virus.  While the findings presented here are consistent 
with those of Chapter IV, it appears that the rate of infection may be occurring faster in 
the EM time course experiment compared to the EM analysis in Chapter IV.  This is 
supported by comparing wild-type infection at 6 h p.i. from both EM experiments.  This 
may also account for the differences in DMV alterations observed in the N176A/N237A 
mutant infections from both experiments.  Also, the quality of the membrane staining is 
better in the analysis from Chapter IV than at later times of infection in the EM time 
course.  Therefore, a more comprehensive time course, e.g. 1 h intervals from 2 to 10 h 
p.i., is necessary to confirm nsp4’s function(s) in the formation and organization of virus-
induced membrane modifications.  Lastly, time course experiments using 
immunofluorescence assays will also aid in determining nsp4’s function(s) in the 
formation and stability of replication complexes over the duration of an infection. 
 
Future studies:  glycosylation of nsps 
 Analysis of the nsp3, nsp4, and nsp6 amino acid sequences and biochemical 
studies have shown all of these proteins have transmembrane domains that are likely 
critical for virus-induced membrane modifications (Baliji et al., 2009; Kanjanahaluethai 
et al., 2007; Oostra et al., 2007).  Moreover, these reports have also analyzed the 
topology of these three proteins and have shown that the N- and C-termini of nsp3, nsp4, 
and nsp6 are all located within the cytoplasm.  Research presented in this dissertation has 
shown that nsp4 is N-glycosylated during infection, and another study has demonstrated 
that nsp3 is N-glycosylated through plasmid expression of nsp3 (Table 5.2), which is 
consistent with glycosylation of these proteins in the ER lumen and lack of trafficking 
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nsp 
No. of Putative N-linked 
Glycosylation Sites 
1 2 
2 2 
3 
7  
(1 confirmed in vitro) 
4 
2 
(2 confirmed during 
replication) 
5 1 
6 0 
7 0 
8 1 
9 1 
10 0 
12 2 
13 4 
14 1 
15 2 
16 4 
 
 
 
 
 
Table 5.2.  Number of putative and confirmed N-linked glycosylation sites of MHV replicase 
proteins.  The numbers of N-X-S and N-X-T glycosylation sequences in each replicase protein are 
indicated in the right column.  The rarely N-linked glycosylated sequence N-X-C was not added to 
the number of N-linked glycosylation sites in the table.  X stands for any amino acid except 
proline. 
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through Golgi (Kanjanahaluethai et al., 2007).  Upon amino acid sequence analysis of all 
the replicase proteins, all have predicted N-linked glycosylation sites, except for nsp6 and 
nsp7 (Table 5.2).  This dissertation has shown that glycosylation of nsp4 is critical for 
viral RNA synthesis and virus-induced membrane modifications; therefore, glycosylation 
of other nsps may be important for their overall functions.  Specifically, it will be 
interesting to see if nsp3 is N-glycosylated during infection and what effects nsp3 
glycosylation has on replication complex function and virus-induced membrane 
structures. 
 If any of the nsps that exhibit putative N-linked glycosylation sites, besides nsp3 
and nsp4, are actually glycosylated, the specific proteins most likely would have to be  
shuttled into the ER lumen, since all the N- and C-termini of the transmembrane proteins 
nsp3, nsp4, and nsp6 are presumably located in the cytoplasm.  Another possibility is that 
the predicted topology of nsp3, nsp4, and/or nsp6 is inaccurate, leading to the N-linked 
glycosylation of specific nsps.  It is likely, though, that the C-terminus of nsp6 is 
cytoplasmic because data presented in Chapter IV has shown that nsp8 is not 
glycosylated in the ER, even though it has a putative N-linked glycosylation site.  This 
would also suggest that any nsps downstream of nsp6 would not exhibit N-linked 
glycosylation unless the specific nsp was shuttled or translocated into the ER.   
 Currently, coronavirus RNA synthesis and the formation of virus-induced 
membrane structures are not well understood.  While the exact sites of viral RNA 
synthesis are unknown, viral RNA has been shown to localize on DMVs and CMs, as 
well as on the inside of DMVs.  Coronavirus nsps have also been shown to localize to 
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these same structures, which are a reticulovesicular network of membrane 
rearrangements.  Because N-linked glycosylation occurs in the ER and DMVs and CMs 
are formed from or utilize hijacked ER membranes, analysis of the glycosylation events 
and status of certain nsps, specifically those that have been implicated in membrane 
rearrangements, RNA binding, and RNA synthesis, will provide a better understanding of 
where and how viral RNA synthesis occurs, how viral RNA is protected from detection 
and degradation by the cell, and how viral RNA is shuttled from sites of synthesis to sites 
of virion assembly.   
 
Concluding remarks 
 Positive-strand RNA viruses are similar in many ways.  These include:  (1) their 
genomes function as mRNAs; (2) they replicate within the cytoplasm of host cells; (3) 
they utilize polyprotein processing as a mechanism to regulate protein expression and 
function; and (4) they induce membrane modifications and rearrangements of host cell 
membranes to form structures that support their viral RNA synthesis.  These areas of 
overlap exhibited by all positive-strand RNA viruses are key avenues of research to better 
understand their life cycles and other important events that take place during infection, 
which will lead to potential vaccines and therapeutics that aid in the prevention and 
alleviation of diseases caused by these viruses.  This dissertation has presented new 
research in several of these areas of interest, including polyprotein processing, the 
importance of genome organization, and replication complex structure and organization. 
 Basic scientific research is the foundation for discoveries that increase our 
understanding and knowledge of the world around us, and graduate school education is a 
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major contributor to these discoveries.  The underlying purpose of any graduate 
education is learning and developing how to analyze and answer simple to complex 
problems by critically thinking about, evaluating, and answering the questions that 
address the problem at hand.  This ability is fundamental in any discipline of basic 
scientific research. 
 The research presented in this dissertation is my modest contribution to the basic 
sciences and the field of microbiology.  It is with hope that the data and reagents 
described in this dissertation will provide a basis for the future investigation of the cell 
biology and replication of positive-strand RNA viruses and aid in the development of 
vaccines and therapeutics to prevent and combat virus infections.  
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CHAPTER VI 
 
MATERIAL AND METHODS 
 
Wild-type virus, cells, and antibodies 
Recombinant wild-type MHV strain A59 (wt; GenBank accession number 
AY910861) was used as the wild-type control for all experiments.  Delayed brain tumor 
(DBT) cells expressing the MHV receptor carcinoembryonic antigen cell adhesion 
molecule-1 (Chen et al., 1997; Hirano, Fujiwara, and Matumoto, 1976; Yount et al., 
2002) and baby hamster kidney cells expressing the MHV receptor (BHK-MHVR) (Chen 
and Baric, 1996; Chen et al., 1997; Yount et al., 2002) were grown in Dulbecco’s 
modified Eagle medium (DMEM) (Gibco) supplemented with 10% fetal calf serum 
(FCS) for all experiments.  Medium for BHK-MHVR cells was supplemented with G418 
(Mediatech) at 0.8 mg/ml to maintain selection for cells expressing the MHVR.  
Rabbit polyclonal antibodies were used in biochemical experiments and have 
been previously described.  Antibodies include include α-nsp1 (VU221)(Brockway et al., 
2004), α-nsp2 (VU154)(Sims, Ostermann, and Denison, 2000), α-nsp3 (VU164)(Graham 
et al., 2005), α-nsp4 (VU158)(Sparks, Lu, and Denison, 2007), α-nsp8 (VU123) (Bost, 
Prentice, and Denison, 2001), and α-M (J.1.3) (Brockway et al., 2003). 
 
Construction and generation of mutant MHV cDNA plasmids 
 Mutant cDNA plasmids that contained the desired mutations were generated 
through multiple PCR techniques.  All PCR reactions were performed with the following 
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parameters:  initial denaturation at 95°C once for 2 min, denaturation at 95°C for 75 s, 
annealing at various temperatures, depending on the melting temperature of the primers, 
for 75 s, extension at 72°C for 1 min per kilobase, and repeating the denaturing, 
annealing, and extension steps for a total of 35 to 45 cycles. 
 For MHV nsp2 duplication, insertion, and mutagenesis, several PCR mutagenesis 
strategies were performed.  Primers listed in Table 2.1 were used for introduction of 
desired mutations into the fragment of interest.  Insertion of nsp2 in ORF1b was achieved 
by generating compatible restriction overhangs by PCR.  The PCR products to introduce 
nsp2 in ORF1b were ligated, and ligations were then cloned into Fragment F using native 
Drd I and BstB I restriction sites.  Deletion of ORF4 and insertion of nsp2 in place of 
ORF4 were also generated using this method.  For deletion of ORF4, PCR was performed 
using primers that would delete ORF4, and ligations were then cloned into fragment G 
using Mlu I and EcoR V sites.  Insertion of nsp2 in place of ORF4 was achieved by 
ligating the PCR products, and the ligations that contained the nsp2 coding sequence in 
place of ORF4 was introduced into fragment G using using Mlu I and EcoR V restriction 
sites.  Additions to the N- and C-terminus of nsp2 were added using the splicing by 
overlap extension method, and PCR products with the N- and C-terminal nsp2 mutations 
were digested, along with fragment A, and the digested PCR product was ligated into the 
fragment.  The constructs generated for all mutations were confirmed by sequencing. 
 For substitution of the position 4 through position 1 (P4 – P1) CS amino acids at 
CS1 and CS2 (ORF1a nucleotides 939 to 950 and 2694 to 2705, respectively), PCR 
mutagenesis was performed using the MHV-A59 infectious clone fragment A (pCR-XL-
TopoA), which consists of nucleotides 1 to 4882, as template DNA(Yount et al., 2002).  
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The splicing by overlap extension method with the ExSite/QuikChange mutagenesis kit 
(Stratagene) was used to replace CS1 with CS3(Horton et al., 1989).  Changes to the 
manufacturer’s protocol include the use of Pfu Turbo DNA polymerase instead of the 
ExSite DNA polymerase mix.  For substitution of CS2 with CS3, PCR mutagenesis with 
primers that amplified all of fragment A was performed with the Fail-Safe PCR kit 
(Epicentre).  For CS3 replacement of CS1, PCR products were gel purified, digested with 
restriction endonucleases SacII and AleI and ligated into fragment A that had also been 
digested with SacII and AleI.   
 For introduction of both CS substitutions into the same fragment, restriction 
endonucleases SacII and AleI were used to digest both fragments containing the mutated 
CSs.  The fragment that contained CS1 replaced by CS3 was then ligated into fragment A 
containing substitution of CS2 by the CS3 sequence.  Lastly, a catalytically inactive 
PLP1 (PLP1ko)(Graham and Denison, 2006), where the catalytic Cys and adjacent Trp 
residues are mutated to Ala, and both CS substitutions were engineered into the same 
fragment by restriction endonuclease digestion with XhoI of a fragment containing the 
CS1 to CS3 substitution and of a fragment containing both the CS2 to CS3 substitution 
and the PLP1ko mutation.  The fragments were then ligated overnight at 16°C.  All 
generated cDNA fragments were sequenced to confirm the introduced mutations and 
absence of spontaneous mutations. 
 For introduction of asparagine-to-alanine substitutions in the nsp4 coding 
sequence (ORF1a nucleotides 8721 to 10208), PCR was performed using the MHV-A59 
infectious clone fragment B (pCR-XL-pSMART B) as a template.  Fragment B of the 
MHV-A59 clone contains MHV ORF1a nsp4 nucleotides 8721 to 9555 (Yount et al., 
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2002).  Asparagine-to-alanine codon changes were introduced using the 
ExSite/QuikChange mutagenesis kit (Stratagene) with primers in Table 4.1.  Changes to 
the manufacturer’s protocol included the use of Pfu Turbo and Pfu Ultra instead of the 
ExSite DNA polymerase blend.  Products were ligated and sequenced across the MHV 
genome-containing region of fragment B to ensure that PCR amplification did not 
introduce any unintended mutations.  For introduction of both N176A and N237A, 
restriction endonuclease EcoN I was used to digest both single nsp4 glycosylation mutant 
plasmids, and ligation was used to introduce both mutations into the same plasmid.  The 
plasmid was then sequenced to confirm the engineered mutations and absence of 
unintended muations. 
 
Generation of MHV mutant viruses 
 Viruses containing the engineered mutations within the MHV genome were 
produced using the infectious cDNA assembly strategy for MHV-A59 that has been 
previously described by Yount et al. (Yount et al., 2002) and modified by Denison et al. 
(Denison et al., 2004) and Sparks et al (Sparks, Lu, and Denison, 2007).  Briefly, 
plasmids containing the seven cDNA cassettes that make up the MHV genome were 
digested using the appropriate restriction enzymes.  The correct restriction fragments 
were gel-purified and ligated together overnight at 16°C.  The ligated DNA was purified, 
in vitro transcribed, and electroporated with N gene transcripts into BHK-MHVR cells. 
The electroporated cells were then laid over a layer of 2.5 × 106 uninfected DBT cells in a 
75 cm2 flask and incubated at 37°C.  Virus viability was determined by cytopathic effect 
(CPE), in this case syncytia formation, in the electroporated cell culture.  Progeny virus 
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in the cell culture medium of electroporated cells (passage 0 [P0]) was passaged onto 
uninfected DBT cells (P1), and the virus released from cells in the culture medium was 
designated as the P1 stock, which was titered and used for all experiments.   
 
RT-PCR and sequencing of recovered viruses 
Total intracellular RNA was harvested from P1-infected cells using TRIzol 
(Invitrogen) according to the manufacturer’s protocol.  Extracted RNA was used as a 
template for RT-PCR.  Reverse transcription was performed using Superscript III reverse 
transcriptase (Invitrogen) and random hexamers (Roche).  Primers complementary to 
genome nucleotides of sense and antisense polarity were then used to amplify the coding 
region of interest by PCR.  These PCR products were sequenced to confirm the retention 
of the engineered mutations and the absence of additional mutations in the coding 
sequence of interest. For full genome sequencing, primers complementary to specific 
genome sequences were amplified by PCR using the reverse transcription products to 
produce amplicons that covered the entire genome. The amplicons were gel purified and 
directly analyzed by automated DNA sequencing. 
 
Protein immunoprecipitations 
For steady-state radiolabeling of proteins and immunoprecipitations, cells were 
grown on 60-mm dishes and infected at an MOI of 1, 5, or 10 PFU/cell with wt or MHV 
mutant viruses and incubated at 37°C.  At 4 to 5.5 h p.i., medium was aspirated and 
replaced with medium lacking methionine and cysteine and supplemented with Act D 
(Sigma) at a final concentration of 20 µg/ml.  After addition of Act D for 30 min to 1 h, 
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cells were radiolabeled with [35S] methionine-cysteine ([35S]Met-Cys) at a concentration 
of 0.08 mCi/ml.  When cells reached ~90% involvement in syncytia, radiolabeled cells 
were washed once in PBS and then lysed in 1 ml of lysis buffer lacking sodium dodecyl 
sulfate (SDS) (1%  NP-40, 0.5% sodium deoxycholate, 150 mM NaCl, and 50 mM Tris, 
pH 8.0).  Lysates were then centrifuged at 6,000 × g for 3 minutes to remove cellular 
debris and nuclei, and the supernatant was collected.  Immunoprecipitations were 
performed in a final volume of 1 ml, using protein A-sepharose beads (Sigma), 50 to 100 
µl of radiolabeled lysate, 1:200 or  1:500 dilutions of polyclonal antisera, and proteinase 
inhibitor (Roche) in lysis buffer.  Immunoprecipitations were then performed as 
previously described (Sparks, Lu, and Denison, 2007).   
For pulse-chase analysis, DBT cells were infected with an MOI of 10 PFU/cell.  
At 6 h p.i., cells were trypsinized and resuspended in 10 ml total volume of media.  Cells 
were centrifuged for 5 min at 1000 RPM, and the cells were resuspended and rotated in a 
1.5 ml eppendorf tube with medium lacking methionine and cysteine and supplemented 
with Act D (Sigma) at a final concentration of 20 µg/ml.  At 7 h p.i., cells were 
radiolabeled with [35S]Met-Cys at a concentration of 0.08 mCi/ml for 1 hour.  Cells were 
centrifuged, washed once with prewarmed PBS, and resuspended in 1 ml of complete 
media with 100 µg/ml cycloheximide.  The predetermined time points were harvested, 
washed once in PBS, and harvested with lysis buffer.  Immunoprecipitations were then 
performed as noted above. 
For endoglycosidase H (Endo H) treatment, supernatant was transferred to a new 
tube after heating at 70°C for 10 min.  Endo H (Sigma) was added to the supernatant 
according to the manufacturer’s protocol, and the mixture was incubated at 37°C for 3 h. 
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Proteins were resolved by SDS-PAGE in 4 to 12% polyacrylamide gradient Bis-
Tris gels (NuPage; Invitrogen) and analyzed by fluorography.  14C-labeled high 
molecular weight markers (NEB) and a full-range rainbow marker were used as 
molecular weight standards. 
 
Viral growth assays 
 For viral growth determination (Denison et al., 2004), DBT cells were infected 
with wt or nsp4 glycosylation mutant viruses at the MOIs indicated.  Following a 45 min 
absorption period at 37°C with periodic swirling, medium was aspirated, and the cells 
were washed three times in PBS.  Prewarmed 37°C medium was then added back to the 
cells, and the cells were incubated at 37°C.  Aliquots of medium were taken from 1 to 30 
h p.i., and virus titers were determined by plaque assay as previously described(Kim et 
al., 1995). 
 
Genomic and subgenomic viral RNA analysis 
 For genomic and subgenomic analysis of viral RNA, cells in 60-mm dishes were 
mock-infected or infected at an MOI of 5 PFU/cell.  Following a 45 min absorption at 
37°C, medium containing virus was removed, and cells were washed twice in PBS.  Cells 
were pretreated with ActD from 8.5 to 9 h p.i., after which [3H]uridine was added to a 
final concentration of 50 µCi/ml, and cells were incubated for 2 h. At 11 h p.i., total 
intracellular RNA was isolated using TRIzol reagent (Invitrogen) according to the 
manufacturer's protocol. From the total volume of each RNA sample, 2.5% was denatured 
using glyoxal loading dye (Ambion) at 50°C for 30 min and resolved by electrophoresis 
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in 1% agarose gels.  After electrophoresis, gels were incubated in 100% methanol for 1 h, 
in 1% 2,5-diphenyloxazole in methanol for 1 h, and in water for 2 h. Gels were then dried 
by vacuum filtration at 50°C and exposed to X-ray film. 
 
Metabolic labeling of viral RNA 
 DBT cells were either mock-infected or infected at an MOI of 5 PFU/cell with wt 
or nsp4 glycosylation mutant viruses in 6-well plates.  Following a 45 min absorption at 
37°C, medium containing virus was removed, and cells were washed twice in PBS.  Cells 
were then incubated in growth medium at 37°C until 30 min prior to labeling, when 
medium was replaced with fresh medium containing 20 µg/ml Act D.  After this 30 min 
treatment, [3H]uridine was added to a final concentration of 40 µCi/ml, and cells were 
incubated at 37°C for 2 h intervals from 3 to 15 h p.i.  At the end of each labeling period, 
cells were lysed in lysis buffer (described above), and nuclei were removed by 
centrifugation at 14,000 × g for 3 min.  RNA in 10% of each lysate was precipitated with 
chilled 5% trichloroacetic acid (TCA) onto glass microfiber filters (Whatman), washed 
twice in fresh 5% TCA and twice in 95% ethanol, and dried using vacuum filtration.  
Radiolabel incorporation was quantitated by liquid scintillation counting. 
 
Immunofluorescence assays 
 DBT cells grown on glass coverslips were infected with wt or nsp4 glycosylation 
mutant viruses at an MOI of 10 PFU/cell.  At 6 h p.i., medium was aspirated from cells, 
and cells were fixed in 100% methanol at -20°C.  Cells were rehydrated in PBS for 10 
min, blocked in PBS containing 5% bovine serum albumin (BSA), and then aspirated.  
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For indirect immunofluorescence, cells were incubated with primary antibody (α-nsp2, 
1:200; α-nsp4, 1:200; α-M, 1:1000) in wash solution (PBS containing 1% BSA and 
0.05% NP-40) for 1 h at room temperature.  Cells were washed in wash solution three 
times for 5 min/wash.  Cells were then incubated with secondary antibody ( goat α-
rabbit-Alexa 488, 1:1000; goat anti-mouse Alexa 546, 1:1000; Molecular Probes) for 30 
min at room temperature.  Cells were washed again three times for 5 min/wash, followed 
by a final wash in PBS, and rinsed with distilled water.  For direct immunofluorescence, 
α-nsp8 was purified using HiTrap rProtein A FF columns (GE Life Sciences) for fast 
protein liquid chromatography.  α-nsp8 was directly conjugated using the Alexa Fluor 
488 or 546 protein labeling kit (Invitrogen) according to the manufacturer’s protocol.  
Cells were incubated with α-nsp8 at a concentration of 1:500, following the same 
procedure as above.  Coverslips were mounted with Aquapolymount (Polysciences) and 
visualized using a Zeiss LSM510 or a Zeiss Axiovert 200 microscope with a 40× oil 
immersion lens.  Images were processed and merged using Adobe Photoshop CS2 or 
CS3. 
 
Transmission electron microscopy (TEM) analysis 
 DBT cells were mock-infected or infected with wt or nsp4 glycosylation mutant 
viruses at an MOI of 5 PFU/cell in a 60-mm dish and incubated at 37°C.  At 6 h p.i., 
medium was aspirated, and cells were washed once with PBS.  The cells were then fixed 
in 2% glutaraldehyde for 10 minutes, scraped off the dishes, and centrifuged at 0.5 × g 
for 3 min.  The initial 2% glutaraldehyde was aspirated, fresh 2% glutaraldehyde was 
added to the fixed cells for 1 h, aspirated, and fresh glutaraldehyde was added to the fixed 
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cells for overnight incubation at 4°C. Cells were washed three times in PBS, transferred 
to 1% osmium tetroxide in diH2O for 1 h, and washed three times in diH2O.  Cells were 
stained en bloc in 1% aqueous uranyl acetate for 1 h, and washed three times in diH2O.  
Dehydration of cells was carried out gradually using graded series of ethanol and 
increasing the times each remained in solution, starting with 30%, followed by 50%, 
70%, 95%, and finally absolute ethanol.  Propylene oxide was used as a transitional 
solvent to replace the dehydration solution. Cells were transferred to a 1:1 
araldite:propylene oxide mixture for 1 hour and then placed in pure araldite in a vacuum 
oven for another hour to help pull resin through the tissue. Pure resin specimens were 
then transferred into capsules containing fresh resin and finally placed into an oven 
overnight to polymerize. Ultra-thin serial sections (50-60 nm) from polymerized blocks 
were obtained using a Leica UCT Ultracut microtome (Leica Microsystems, Vienna, 
Austria), transferred to formvar-coated slot grids, and examined using a Phillips CM10 
TEM (FEI Company, Hillsboro, OR) equipped with an Advantage Plus 2 megapixel 
Digital CCD System for CM10 TEM (Advanced Microscopy Techniques, Danvers, 
MA).  
 
Statistical analyses 
 For statistical analyses, DMVs were characterized into two groups, either regular 
(defined by inner membranes in close approximation with the outer membrane) or 
irregular DMVs (defined by moderate to severe disruption or separation of the inner 
membrane with the outer membrane).  Chi square analysis using contingency tables was 
performed comparing the number of regular-formed DMVs to irregular-formed DMVs of 
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wt and nsp4 glycosylation mutant viruses.  Chi square analysis was also performed to 
compare the presence of both CMs and DMVs to the presence of DMVs only.  Because 
CMs were only found in the presence of DMVs, the presence of CMs and DMVs was 
compared to the presence of DMVs alone in a given TEM section.  Diameters of DMVs 
were measured using ImageJ 1.40g (http://rsb.info.nih.gov/ij).  Diameters were defined 
by measuring the widest diameter from the outside membrane of one side to the outside 
membrane of the opposite side of a single DMV.  To determine whether there was a 
statistical difference between the diameters of DMVs, analysis of variance (ANOVA) 
was used to compare wt and nsp4 glycosylation mutant viruses.  Because a statistical 
difference was indicated through ANOVA, Tukey tests were used to perform pair-wise 
comparisons of all viruses.  P values were determined to indicate significance. 
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APPENDIX A 
 
 
MURINE CORONAVIRUSES ENCODING NSP2 AT DIFFERENT GENOMIC LOCI 
HAVE ALTERED REPLICATION, PROTEIN EXPRESSION, AND LOCALIZATION 
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APPENDIX B 
 
 
MURINE HEPATITIS VIRUS NONSTRUCTURAL PROTEIN 4 REGULATES 
VIRUS-INDUCED MEMBRANE MODIFICATIONS AND REPLICATION 
COMPLEX FUNCTION
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